VEGF mimic peptides: Potential applications in central nervous system therapeutics (624 views)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 0, 5-year impact factor: 0
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012254796&doi=10.1016%2fj.nhtm.2016.12.002&partnerID=40&md5=c0d02f11f1e9548529414a6ed55138fd
Keywords: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Epilepsy, Intranasal Administration, Neurodegeneration, Parkinson, S Disease, Qk Peptide, Stroke, Vegf, Vasculotropin, Untranslated Region, Brain Disease, Central Nervous System, Cerebrovascular Accident, Crystal Structure, Crystallography, Genetic Polymorphism, Genetic Transcription, Human, Nerve Regeneration, Neuroprotection, Parkinson Disease, Priority Journal, Protein Expression, Protein Phosphorylation, Review, Tissue Repair,
Affiliations:
*** IBB - CNR ***
Institute of Biostructure and Bioimaging, National Research Council, Naples, Italy
Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatologic Sciences, Federico II University of Naples, Italy
References:
Baumgartner, I., Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor (2000) Curr. Cardiol. Rep., 2, pp. 24-2
Hendel, R.C., Henry, T.D., Rocha-Singh, K., Isner, J.M., Kereiakes, D.J., Giordano, F.J., Simons, M., Bonow, R.O., Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect (2000) Circulation, 101, pp. 118-121
Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., McCluskey, E.R., VIVA Investigators, The VIVA trial: vascular endothelial growth factor in Ischemia for vascular angiogenesis (2003) Circulation, 107, pp. 1359-1365
Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Isner, J.M., Therapeutic angiogenesis. a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model (1994) J. Clin. Invest., 93, pp. 662-670
Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., Carmeliet, P., Role and therapeutic potential of VEGF in the nervous system (2009) Physiol. Rev., 89, pp. 607-648
Lange, C., Storkebaum, E., de Almodóvar, C.R., Dewerchin, M., Carmeliet, P., Vascular endothelial growth factor: a neurovascular target in neurological diseases (2016) Nat. Rev. Neurol., 12, pp. 439-454
Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J., Ferrara, N., Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms (1992) J. Biol. Chem., 267, pp. 26031-26037
Park, J.E., Keller, G.A., Ferrara, N., The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF (1993) Mol. Biol. Cell., 4, pp. 1317-1326
Ortéga, N., L'Faqihi, F.E., Plouët, J., Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix (1998) Biol. Cell., 90, pp. 381-390
Amin, E.M., Oltean, S., Hua, J., Gammons, M.V., Hamdollah-Zadeh, M., Welsh, G.I., Cheung, M.K., Ladomery, M.R., WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing (2011) Cancer Cell., 20, pp. 768-780
Eswarappa, S.M., Potdar, A.A., Koch, W.J., Fan, Y., Vasu, K., Lindner, D., Willard, B., Fox, P.L., Programmed translational readthrough generates antiangiogenic VEGF-Ax (2014) Cell, 157, pp. 1605-1618
Harris, S., Craze, M., Newton, J., Fisher, M., Shima, D.T., Tozer, G.M., Kanthou, C., Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale (2012) PLoS One, 7, p. e35231
Xin, H., Zhong, C., Nudleman, E., Ferrara, N., Evidence for Pro-angiogenic Functions of VEGF-Ax (2016) Cell, 167, pp. 275-284
Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C., de Vos, A.M., Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 7192-7197
Muller, Y.A., Christinger, H.W., Keyt, B.A., de Vos, A.M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338
Ferrara, N., Gerber, H.P., LeCouter, J., The biology of VEGF and its receptors (2003) Nat. Med., 9, pp. 669-676
Cao, Y., Positive and negative modulation of angiogenesis by VEGFR1 ligands.Sci (2009) Signal, 2. , (re1)
Cross, M.J., Dixelius, J., Matsumoto, T., Claesson-Welsh, L., VEGF-receptor signal transduction (2003) Trends Biochem. Sci., 28, pp. 488-494
Shibuya, M., Claesson-Welsh, L., Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis (2006) Exp. Cell. Res., 312, pp. 549-560
Olsson, A.K., Dimberg, A., Kreuger, J., Claesson-Welsh, L., VEGF receptor signalling in control of vascular function (2006) Nat. Rev. Mol. Cell. Biol., 7, pp. 359-371
Gélinas, D.S., Bernatchez, P.N., Rollin, S., Bazan, N.G., Sirois, M.G., Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways (2002) Br. J. Pharmacol., 137, pp. 1021-1030
Rosenstein, J.M., Krum, J.M., Ruhrberg, C., VEGF in the nervous system (2010) Organogenesis, 6, pp. 107-114
Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L., Greenberg, D.A., Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 11946-11950
Licht, T., Keshet, E., Delineating multiple functions of VEGF-A in the adult brain (2013) Cell. Mol. Life Sci., 70, pp. 1727-1737
Carmeliet, P., Ruiz de Almodovar, C., VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration (2013) Cell. Mol. Life Sci., 70, pp. 1763-1778
Jin, K., Mao, X.O., Batteur, S.P., McEachron, E., Leahy, A., Greenberg, D.A., Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor (2001) Neuroscience, 108, pp. 351-358
Jin, K.L., Mao, X.O., Greenberg, D.A., Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 10242-10247
Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N., Tohyama, M., Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades (2001) FASEB J., 15, pp. 1218-1220
Svensson, B., Peters, M., König, H.G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Prehn, J.H., Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism (2002) J. Cereb. Blood Flow. Metab., 22, pp. 1170-1175
Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., Ferrara, N., Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation (1998) J. Biol. Chem., 273, pp. 30336-30343
Yu, S., Liu, Y.P., Liu, Y.H., Jiao, S.S., Liu, L., Wang, Y.J., Fu, W.L., Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients (2016) Clin. Chim. Acta, 453, pp. 154-159
Yu, S.P., Farhangrazi, Z.S., Ying, H.S., Yeh, C.H., Choi, D.W., Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death (1998) Neurobiol. Dis., 5, pp. 81-88
Xu JY, J.Y., Zheng, P., Shen, D.H., Yang, S.Z., Zhang, L.M., Huang, Y.L., Sun, F.Y., Vascular endothelial growth factor inhibits outward delayed-rectifier potassium currents in acutely isolated hippocampal neurons (2003) Neuroscience, 118, pp. 59-67
Qiu, M.H., Zhang, R., Sun, F.Y., Enhancement of ischemia-induced tyrosine phosphorylation of Kv1.2 by vascular endothelial growth factor via activation of phosphatidylinositol 3-kinase (2003) J. Neurochem., 87, pp. 1509-1517
Huang, X.Y., Morielli, A.D., Peralta, E.G., Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor (1993) Cell, 75, pp. 1145-1156
Wu, K.W., Yang, P., Li, S.S., Liu, C.W., Sun, F.Y., VEGF attenuated increase of outward delayed-rectifier potassium currents in hippocampal neurons induced by focal ischemia via PI3-K pathway (2015) Neuroscience, 298, pp. 94-101
Ma, Y.Y., Li, K.Y., Wang, J.J., Huang, Y.L., Huang, Y., Sun, F.Y., Vascular endothelial growth factor acutely reduces calcium influx via inhibition of the Ca2+ channels in rat hippocampal neurons (2009) J. Neurosci. Res., 87, pp. 393-402
Kim, B.W., Choi, M., Kim, Y.S., Park, H., Lee, H.R., Yun, C.O., Kim, E.J., Son, H., Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin (2008) Cell. Signal, 20, pp. 714-725
Sun, G.C., Ma, Y.Y., Vascular endothelial growth factor modulates voltage-gated Na+channel properties and depresses action potential firing in cultured rat hippocampal neurons (2013) Biol. Pharm. Bull., 36, pp. 548-555
Palmer, T.D., Willhoite, A.R., Gage, F.H., Vascular niche for adult hippocampal neurogenesis (2000) J. Comp. Neurol., 425, pp. 479-494
Ward, N.L., Lamanna, J.C., The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems (2004) Neurol. Res., 26, pp. 870-883
Font, M.A., Arboix, A., Krupinski, J., Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke (2010) Curr. Cardiol. Rev., 6, pp. 238-244
Greenberg, D.A., Jin, K., Vascular endothelial growth factors (VEGFs) and stroke (2013) Cell. Mol. Life Sci., 70, pp. 1753-1761
Madri, J.A., Modeling the neurovascular niche: implications for recovery from CNS injury (2009) J. Physiol. Pharmacol., 60, pp. 95-104
Ohab, J.J., Fleming, S., Blesch, A., Carmichael, S.T., A neurovascular niche for neurogenesis after stroke (2006) J. Neurosci., 26, pp. 13007-13016
Zhang, R.L., Chopp, M., Roberts, C., Liu, X., Wei, M., Nejad-Davarani, S.P., Wang, X., Zhang, Z.G., Stroke increases neural stem cells and angiogenesis in the neurogenic niche of the adult mouse (2014) PLoS One, 9, p. e113972
Brumm, A.J., Carmichael, S.T., Not just a rush of blood to the head (2012) Nat. Med., 18, pp. 1609-1610
Muramatsu, R., Takahashi, C., Miyake, S., Fujimura, H., Mochizuki, H., Yamashita, T., Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin (2012) Nat. Med., 18, pp. 1658-1664
Hermann, D.M., Zechariah, A., Implications of vascular endothelial growth factor for postischemic neurovascular remodeling (2009) J. Cereb. Blood Flow. Metab., 29, pp. 1620-1643
Ma, Y., Zechariah, A., Qu, Y., Hermann, D.M., Effects of vascular endothelial growth factor in ischemic stroke (2012) J. Neurosci. Res., 90, pp. 1873-1882
Schmidt, N.O., Przylecki, W., Yang, W., Ziu, M., Teng, Y., Kim, S.U., Black, P.M., Carroll, R.S., Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor (2005) Neoplasia, 7, pp. 623-629
Schmidt, N.O., Koeder, D., Messing, M., Mueller, F.J., Aboody, K.S., Kim, S.U., Black, P.M., Lamszus, K., Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche (2009) Brain Res., 1268, pp. 24-37
LaManna, J.C., Kuo, N.T., Lust, W.D., Hypoxia-induced brain angiogenesis. Signals and consequences (1998) Adv. Exp. Med. Biol., 454, pp. 287-293
Marti, H.J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., Risau, W., Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia (2000) Am. J. Pathol., 156, pp. 965-976
Szade, A., Grochot-Przeczek, A., Florczyk, U., Jozkowicz, A., Dulak, J., Cellular and molecular mechanisms of inflammation-induced angiogenesis (2015) IUBMB Life, 67, pp. 145-159
Caruana, M., Cauchi, R., Vassallo, N., Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease (2016) Front. Nutr., 3, p. 31
Mandel, S.A., Weinreb, O., Amit, T., Youdim, M.B., Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols (2012), pp. 4581-598. , Front. Biosci. (Schol Ed)
Pérez-Hernández, J., Zaldívar-Machorro, V.J., Villanueva-Porras, D., Vega-Ávila, E., Chavarría, A., A Potential alternative against neurodegenerative diseases: phytodrugs (2016) Oxid. Med. Cell Longev., 2016, p. 8378613
Ajami, M., Pazoki-Toroudi, H., Amani, H., Nabavi, S.F., Braidy, N., Vacca, R.A., Atanasov, A.G., Nabavi, S.M., Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols (2016) Neurosci. Biobehav. Rev., , (Epub ahead of print)
Donà, M., Dell'Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A., Garbisa, S., Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis (2003) J. Immunol., 170, pp. 4335-4341
Malhotra, S., Tavakkoli, M., Edraki, N., Miri, R., Sharma, S.K., Prasad, A.K., Saso, L., Firuzi, O., Neuroprotective and antioxidant activities of 4-methylcoumarins: development of structure-activity relationships (2016) Biol. Pharm. Bull., 39, pp. 1544-1548
Lapi, D., Vagnani, S., Pignataro, G., Esposito, E., Paterni, M., Colantuoni, A., Protective Effects of Quercetin on Rat Pial Microvascular Changes during Transient Bilateral Common Carotid Artery Occlusion and Reperfusion (2012) Front. Physiol., 3, p. 32
Albini, A., Tosetti, F., Li, V.W., Noonan, D.M., Li, W.W., Cancer prevention by targeting angiogenesis (2012) Nat. Rev. Clin. Oncol., 9, pp. 498-509
Benelli, R., Venè, R., Bisacchi, D., Garbisa, S., Albini, A., Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases (2002) Biol. Chem., 383, pp. 101-105
Fernando, W., Rupasinghe, H.P., Hoskin, D.W., Regulation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling by plant flavonoids (2015) Mini Rev. Med. Chem., 15, pp. 479-489
Fu, B., Xue, J., Li, Z., Shi, X., Jiang, B.H., Fang, J., Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis (2007) Mol. Cancer Ther., 6, pp. 220-226
Gallo, C., Dallaglio, K., Bassani, B., Rossi, T., Rossello, A., Noonan, D.M., D'Uva, G., Albini, A., Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation (2016) Oncotarget, , (Epub ahead of print)
García-Maceira, P., Mateo, J., Silibinin inhibits hypoxia-inducible factor−1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy (2009) Oncogene, 28, pp. 313-324
Jeon, H., Kim, H., Choi, D., Kim, D., Park, S.Y., Kim, Y.J., Kim, Y.M., Jung, Y., Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase (2007) Mol. Pharmacol., 71, pp. 1676-1684
Zhou, Y.D., Kim, Y.P., Li, X.C., Baerson, S.R., Agarwal, A.K., Hodges, T.W., Ferreira, D., Nagle, D.G., Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts (2004) J. Nat. Prod., 67, pp. 2063-2069
Thomas, R., Kim, M.H., Epigallocatechin gallate inhibits HIF-1a degradation in prostate cancer cells (2005) Biochem. Biophys. Res. Commun., 334, pp. 543-548
Amoroso, S., Gioielli, A., Cataldi, M., Di Renzo, G., Annunziato, L., In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca2+ increase (1999) Biochim. Biophys. Acta, 1452, pp. 151-160
Annunziato, L., Pannaccione, A., Cataldi, M., Secondo, A., Castaldo, P., Renzo, G.D., Taglialatela, M., Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? (2002) Neurobiol. Aging, 23, pp. 819-834
Annunziato, L., Cataldi, M., Pignataro, G., Secondo, A., Molinaro, P., Glutamate-independent calcium toxicity: introduction (2007) Stroke, 38 (2), pp. S661-S664
Zacchigna, S., Lambrechts, D., Carmeliet, P., Neurovascular signalling defects in neurodegeneration (2008) Nat. Rev. Neurosci., 9, pp. 169-181
Hansen, T.M., Moss, A.J., Brindle, N.P., Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke (2008) Curr. Neurovasc. Res., 5, pp. 236-245
Nowacka, M.M., Obuchowicz, E., Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action (2012) Neuropeptides, 46, pp. 1-10
Zachary, I., Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential (2005) Neurosignals, 14, pp. 207-221
Beck, H., Plate, K.H., Angiogenesis after cerebral ischemia (2009) Acta Neuropathol., 117, pp. 481-496
Kovács, Z., Ikezaki, K., Samoto, K., Inamura, T., Fukui, M., VEGF and flt (1996) Expr. Time Kinet. Rat. brain Infarct. Stroke, 27, pp. 1865-1872
Hayashi, T., Abe, K., Suzuki, H., Itoyama, Y., Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats (1997) Stroke, 28, pp. 2039-2044
Lee, M.Y., Ju, W.K., Cha, J.H., Son, B.C., Chun, M.H., Kang, J.K., Park, C.K., Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats (1999) Neurosci. Lett., 265, pp. 107-110
Hai, J., Li, S.T., Lin, Q., Pan, Q.G., Gao, F., Ding, M.X., Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain (2003) Neurosurgery, 53, pp. 963-970
Yang, J., Yao, Y., Chen, T., Zhang, T., VEGF ameliorates cognitive impairment in vivo and in vitro ischemia via improving neuronal viability and function (2014) Neuromol. Med., 16, pp. 376-388
Yang, Z.J., Bao, W.L., Qiu, M.H., Zhang, L.M., Lu, S.D., Huang, Y.L., Sun, F.Y., Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia (2002) J. Neurosci. Res., 70, pp. 140-149
Bao, W.L., Lu, S.D., Wang, H., Sun, F.Y., Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia (1999) Zhongguo Yao Li Xue Bao, 20, pp. 313-318
Shimotake, J., Derugin, N., Wendland, M., Vexler, Z.S., Ferriero, D.M., Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke (2010) Stroke, 41, pp. 343-349
Whitaker, V.R., Cui, L., Miller, S., Yu, S.P., Wei, L., Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice (2007) J. Cereb. Blood Flow. Metab., 27, pp. 57-68
Li, W.L., Fraser, J.L., Yu, S.P., Zhu, J., Jiang, Y.J., Wei, L., The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice (2011) Exp. Brain Res., 214, pp. 503-513
Qiu, S., Wu, T., Wang, P., Li, J., Li, Q., Du, J., The association between VEGFR gene polymorphisms and stroke: a meta-analysis (2016) PLoS One, 11, p. e0151371
Wu, T., Qiu, S., Wang, P., Li, J., Li, Q., Du, J., The association between vascular endothelial growth factor gene polymorphisms and stroke: a meta-analysis (2016) Brain Behav., 6, p. e00482
Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N.V., Chopp, M., VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain (2000) J. Clin. Invest., 106, pp. 829-838
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., Greenberg, D.A., VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia (2003) J. Clin. Invest., 111, pp. 1843-1851
Harrigan, M., Ennis, S., Masada, T., Keep, R., Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema (2002) Neurosurgery, 50, pp. 589-598
Harrigan, M.R., Ennis, S.R., Sullivan, S.E., Keep, R.F., Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume (2003) Acta Neurochir. (Wien.)., 145, pp. 49-53
Manoonkitiwongsa, P.S., Schultz, R.L., McCreery, D.B., Whitter, E.F., Lyden, P.D., Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis (2004) J. Cereb. Blood Flow. Metab., 24, pp. 693-702
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Carmeliet, P., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration (2001) Nat. Genet., 28, pp. 131-138
Green, S.L., Tolwani, R.J., Animal models for motor neuron disease (1999) Lab. Anim. Sci., 49, pp. 480-487
Shefner, J.M., Reaume, A.G., Flood, D.G., Scott, R.W., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Brown, R.H., Jr., Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy (1999) Neurology, 53, pp. 1239-1246
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., Wyns, S., Carmeliet, P., VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (2003) Nat. Genet., 34, pp. 383-394
Lunn, J.S., Sakowski, S.A., Kim, B., Rosenberg, A.A., Feldman, E.L., Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration (2009) Dev. Neurobiol., 69, pp. 871-884
Miyazaki, K., Masamoto, K., Morimoto, N., Kurata, T., Mimoto, T., Obata, T., Kanno, I., Abe, K., Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice (2011) J. Cereb. Blood Flow Metab., 32, pp. 456-467
Sato, K., Morimoto, N., Kurata, T., Mimoto, T., Miyazaki, K., Ikeda, Y., Abe, K., Impaired response of hypoxic sensor protein HIF-1α and its downstream proteins in the spinal motor neurons of ALS model mice (2012) Brain Res., 1473, pp. 55-62
Li, X., Lu, L., Bush, D.J., Zhang, X., Zheng, L., Suswam, E.A., King, P.H., Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region (2009) J. Neurochem., 108, pp. 1032-1044
Lu, L., Zheng, L., Viera, L., Suswam, E., Li, Y., Li, X., Estévez, A.G., King, P.H., Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression (2007) J. Neurosci., 27, pp. 7929-7938
Vijayalakshmi, K., Ostwal, P., Sumitha, R., Shruthi, S., Varghese, A.M., Mishra, P., Manohari, S.G., Alladi, P.A., Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line (2015) Mol. Neurobiol., 51, pp. 995-1007
Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.P., Appelmans, S., Oh, H., Van Damme, P., Carmeliet, P., Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS (2005) Nat. Neurosci., 8, pp. 85-92
Azzouz, M., Ralph, G.S., Storkebaum, E., Walmsley, L.E., Mitrophanous, K.A., Kingsman, S.M., Carmeliet, P., Mazarakis, N.D., VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model (2004) Nature, 429, pp. 413-417
Bogaert, E., Van Damme, P., Poesen, K., Dhondt, J., Hersmus, N., Kiraly, D., Scheveneels, W., Van Den Bosch, L., VEGF protects motor neurons against excitotoxicity by upregulation of GluR2 (2010) Neurobiol. Aging, 31, pp. 2185-2191
Bridges, R.J., Stevens, D.R., Kahle, J.S., Nunn, P.B., Kadri, M., Cotman, C.W., Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-L-ODAP is a selective non-NMDA agonist (1989) J. Neurosci., 9, pp. 2073-2079
Chase, R.A., Pearson, S., Nunn, P.B., Lantos, P.L., Comparative toxicities of alpha- and beta-N-oxalyl-L-alpha, beta-diaminopropionic acids to rat spinal cord (1985) Neurosci. Lett., 55, pp. 89-94
Spencer, P.S., Roy, D.N., Ludolph, A., Hugon, J., Dwivedi, M.P., Schaumburg, H.H., Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA (1986) Lancet, 2-8515, pp. 1066-1067
Hugon, J., Ludolph, A., Roy, D.N., Schaumburg, H.H., Spencer, P.S., Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus and IDPN (1988) Neurology, 38, pp. 435-442
Devos, D., Moreau, C., Lassalle, P., Perez, T., De Seze, J., Brunaud-Danel, V., Destée, A., Just, N., Low levels of the vascular endothelial growth factor in CSF from early ALS patients (2004) Neurology, 62, pp. 2127-2129
Canosa, A., Calvo, A., Barberis, M., Brunetti, M., Restagno, G., Cammarosano, S., Ilardi, A., Moglia, C., Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor (2015) Amyotroph. Lateral Scler. Front. Degener., 16, pp. 129-130
Lambrechts, D., Poesen, K., Fernández-Santiago, R., Al-Chalabi, A., Del Bo, R., Van, P.W., Vught, S., Carmeliet, P., Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype (2009) J. Med. Genet., 46, pp. 840-846
Chen, D., Shen, L., Wang, L., Lu, A., Zhang, H., Zhang, X., Zhang, Y., Zhang, J., Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis (2007) Amyotroph. Lateral Scler., 8, pp. 144-149
Chen, W., Saeed, M., Mao, H., Siddique, N., Dellefave, L., Hung, W.Y., Deng, H.X., Siddique, T., Lack of association of VEGF promoter polymorphisms with sporadic ALS (2006) Neurology, 67, pp. 508-510
Del, R., Scarlato, B.M., Ghezzi, S., Martinelli-Boneschi, F., Corti, S., Locatelli, F., Santoro, D., Comi, G.P., Absence of angiogenic genes modification in Italian ALS patients (2008) Neurobiol. Aging, 29, pp. 314-316
Gros-Louis, F., Laurent, S., Lopes, A.A., Khoris, J., Meininger, V., Camu, W., Rouleau, G.A., Absence of mutations in the hypoxia response element of VEGF in ALS (2003) Muscle Nerve, 28, pp. 774-775
Van Vught, P.W., Sutedja, N.A., Veldink, J.H., Koeleman, B.P., Groeneveld, G.J., Wijmenga, C., Uitdehaag, B.M., Van den Berg, L.H., Lack of association between VEGF polymorphisms and ALS in a Dutch population (2005) Neurology, 65, pp. 1643-1645
Zhang, Y., Zhang, H., Fu, Y., Song, H., Wang, L., Zhang, J., Fan, D., VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients (2006) Amyotroph. Lateral Scler., 7, pp. 119-122
Brockington, A., Wokke, B., Nixon, H., Hartley, J., Shaw, P.J., Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis (2007) BMC Med. Genet., 8, p. 23
Cataldi, M., The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases (2013) Curr. Neuropharmacol., 11, pp. 276-297
Kalaria, R.N., Small vessel disease and Alzheimer's dementia: pathological considerations (2002) Cerebrovasc. Dis., 13, pp. S48-S52
Meyer, E.P., Ulmann-Schuler, A., Staufenbiel, M., Krucker, T., Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 3587-3592
Bozzao, A., Floris, R., Baviera, M.E., Apruzzese, A., Simonetti, G., Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load (2001) AJNR Am. J. Neuroradiol., 22, pp. 1030-1036
Matsuda, H., Cerebral blood flow and metabolic abnormalities in Alzheimer's disease (2001) Ann. Nucl. Med., 15, pp. 85-92
Ellis, R.J., Olichney, J.M., Thal, L.J., Mirra, S.S., Morris, J.C., Beekly, D., Heyman, A., Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV (1996) Neurology, 46, pp. 1592-1596
Esiri, M.M., Wilcock, G.K., Cerebral amyloid angiopathy in dementia and old age (1986) J. Neurol. Neurosurg. Psychiatry, 49, pp. 1221-1226
Love, S., Miners, J.S., Cerebral hypoperfusion and the energy deficit in Alzheimer's disease (2016) Brain Pathol., 26, pp. 607-617
Kalaria, R.N., Cohen, D.L., Premkumar, D.R., Nag, S., LaManna, J.C., Lust, W.D., Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia (1998) Brain Res. Mol. Brain Res., 62, pp. 101-105
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., Kumar, P., Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia (2002) Neurobiol. Aging, 23, pp. 237-243
Thirumangalakudi, L., Samany, P.G., Owoso, A., Wiskar, B., Grammas, P., Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease (2006) J. Alzheimers Dis., 10, pp. 111-118
Barker, R., Ashby, E.L., Wellington, D., Barrow, V.M., Palmer, J.C., Kehoe, P.G., Esiri, M.M., Love, S., Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia (2014) Brain, 137, pp. 1524-1532
Provias, J., Jeynes, B., Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease (2014) Curr. Neurovasc. Res., 11, pp. 202-209
Mateo, I., Llorca, J., Infante, J., Rodríguez-Rodríguez, E., Fernández-Viadero, C., Peña, N., Berciano, J., Combarros, O., Low serum VEGF levels are associated with Alzheimer's disease (2007) Acta Neurol. Scand., 116, pp. 56-58
Craig-Schapiro, R., Kuhn, M., Xiong, C., Pickering, E.H., Liu, J., Misko, T.P., Perrin, R.J., DM, H., Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis (2011) PLoS One, 6, p. e18850
Leung, Y.Y., Toledo, J.B., Nefedov, A., Polikar, R., Raghavan, N., Xie, S.X., Farnum, M., Wang, L.S., Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study (2015) Alzheimers Dement. (Amst.)., 1, pp. 339-348
Hohman, T.J., Bell, S.P., Jefferson, A.L., Alzheimer's disease neuroimaging initiative. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease (2015) JAMA Neurol., 72, pp. 520-529
Chapuis, J., Tian, J., Shi, J., Bensemain, F., Cottel, D., Lendon, C., Amouyel, P., Lambert, J.C., Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease (2006) Neurobiol. Aging, 27, pp. 1212-1215
Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli Boneschi, F., Fenoglio, C., Galbiati, S., Virgilio, R., Comi, G.P., Vascular endothelial growth factor gene variability is associated with increased risk for AD (2005) Ann. Neurol., 57, pp. 373-380
Landgren, S., Palmér, M.S., Skoog, I., Minthon, L., Wallin, A., Andreasen, N., Zetterberg, M., Zetterberg, H., No association of VEGF polymorphims with Alzheimer's disease (2010) Neuromol. Med., 12, pp. 224-228
Liu, S.Y., Zeng, F.F., Chen, Z.W., Wang, C.Y., Zhao, B., Li, K.S., Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis (2013) CNS Neurosci. Ther., 19, pp. 469-476
He, D., Lu, W., Chang, K., Liu, Y., Zhang, J., Zeng, Z., Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis (2013) Gene, 518, pp. 296-302
Johnson, N.A., Jahng, G.H., Weiner, M.W., Miller, B.L., Chui, H.C., Jagust, W.J., Gorno-Tempini, M.L., Schuff, N., Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience (2005) Radiology, 234, pp. 851-859
Paris, D., Patel, N., DelleDonne, A., Quadros, A., Smeed, R., Mullan, M. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis (2004) Neurosci. Lett., 366, pp. 80-85
Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., Mullan, M., Inhibition of angiogenesis by Abeta peptides (2004) Angiogenesis, 7, pp. 75-85
Patel, N.S., Mathura, V.S., Bachmeier, C., Beaulieu-Abdelahad, D., Laporte, V., Weeks, O., Mullan, M., Paris, D., Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2 (2010) J. Neurochem., 112, pp. 66-76
Wang, P., Xie, Z.H., Guo, Y.J., Zhao, C.P., Jiang, H., Song, Y., Zhu, Z.Y., Bi, J.Z., VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease (2011) Biochem. Biophys. Res. Commun., 411, pp. 620-626
Garcia, K.O., Ornellas, F.L., Martin, P.K., Patti, C.L., Mello, L.E., Frussa-Filho, R., Han, S.W., Longo, B.M., Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease (2014) Front. Aging Neurosci., 6, p. 30
Religa, P., Cao, R., Religa, D., Xue, Y., Bogdanovic, N., Westaway, D., Marti, H.H., Cao, Y., VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival (2013) Sci. Rep., 3, p. 2053
Pitzer, M.R., Sortwell, C.E., Daley, B.F., McGuire, S.O., Marchionini, D., Fleming, M., Collier, T.J., Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted andcultured embryonic ventral mesencephalic cells (2003) Exp. Neurol., 182, pp. 435-445
Silverman, W.F., Krum, J.M., Mani, N., Rosenstein, J.M., Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures (1999) Neuroscience, 90, pp. 1529-1541
Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Date, I., Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease (2004) Eur. J. Neurosci., 19, pp. 1494-1504
Tian, Y.Y., Tang, C.J., Wang, J.N., Feng, Y., Chen, X.W., Wang, L., Qiao, X., Sun, S.G., Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors (2007) Neurosci. Lett., 421, pp. 239-244
Ding, Y.H., Luan, X.D., Li, J., Rafols, J.A., Guthinkonda, M., Diaz, F.G., Ding, Y., Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke (2004) Curr. Neurovasc. Res., 1, pp. 411-420
Ding, Y.H., Li, J., Zhou, Y., Rafols, J.A., Clark, J.C., Ding, Y., Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise (2006) Curr. Neurovasc. Res., 3, pp. 15-23
Villar-Cheda, B., Sousa-Ribeiro, D., Rodriguez-Pallares, J., Rodriguez-Perez, A.I., Guerra, M.J., Labandeira-Garcia, J.L., Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease (2009) J. Cereb. Blood Flow. Metab., 29, pp. 230-234
Faucheux, B.A., Bonnet, A.M., Agid, Y., Hirsch, E.C., Blood vessels change in the mesencephalon of patients with Parkinson's disease (1999) Lancet, 353, pp. 981-982
Wada, K., Arai, H., Takanashi, M., Fukae, J., Oizumi, H., Yasuda, T., Mizuno, Y., Mochizuki, H., Expression levels of vascular endothelial growth factor and its recept ors in Parkinson's disease (2006) Neuroreport, 17, pp. 705-709
Pienaar, I.S., Lee, C.H., Elson, J.L., McGuinness, L., Gentleman, S.M., Kalaria, R.N., Dexter, D.T., Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease (2015) Neurobiol. Dis., 74, pp. 392-405
Cui, W., Li, W., Han, R., Mak, S., Zhang, H., Hu, S., Rong, J., Han, Y., PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis (2011) Neurochem. Int., 59, pp. 945-953
Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C.H., Hansson, O., Increased CSF biomarkers of angiogenesis in Parkinson disease (2015) Neurology, 85, pp. 1834-1842
Yao, Y., Tsirka, S.E., Monocyte chemoattractant protein-1 and the blood-brain barrier (2014) Cell. Mol. Life Sci., 71, pp. 683-697
Rite, I., Machado, A., Cano, J., Venero, J.L., Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons (2007) J. Neurochem., 101, pp. 1567-1582
Muñoz, A., Garrido-Gil, P., Dominguez-Meijide, A., Labandeira-Garcia, J.L., Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β (2014) Exp. Neurol., 261, pp. 720-732
Newton, S.S., Collier, E.F., Hunsberger, J., Adams, D., Terwilliger, R., Selvanayagam, E., Duman, R.S., Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors (2003) J. Neurosci., 23, pp. 10841-10851
Nicoletti, J.N., Shah, S.K., McCloskey, D.P., Goodman, J.H., Elkady, A., Atassi, H., Hylton, D., Croll, S.D., Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus (2008) Neuroscience, 151, pp. 232-241
Nikitidou, L., Kanter-Schlifke, I., Dhondt, J., Carmeliet, P., Lambrechts, D., Kokaia, M., VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures (2012) PLoS One, 7, p. e40535
McCloskey, D.P., Croll, S.D., Scharfman, H.E., Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures (2005) J. Neurosci., 25, pp. 8889-8897
Cammalleri, M., Martini, D., Ristori, C., Timperio, A.M., Bagnoli, P., Vascular endothelial growth factor up-regulation in the mouse hippocampus and its role in the control of epileptiform activity (2011) Eur. J. Neurosci., 33, pp. 482-498
Vezzani, A., Friedman, A., Dingledine, R.J., The role of inflammation in epileptogenesis (2013) Neuropharmacology, 69, pp. 16-24
Shimada, T., Takemiya, T., Sugiura, H., Yamagata, K., Role of inflammatory mediators in the pathogenesis of epilepsy (2014) Mediat. Inflamm., 2014, p. 901902
Morin-Brureau, M., Lebrun, A., Rousset, M.C., Fagni, L., Bockaert, J., de Bock, F., Lerner-Natoli, M., Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways (2011) J. Neurosci., 31, pp. 10677-10688
Rhim, T., Lee, D.Y., Lee, M., Drug delivery systems for the treatment of ischemic stroke (2013) Pharm. Res., 30, pp. 2429-2444
Eppler, S.M., Combs, D.L., Henry, T.D., Lopez, J.J., Ellis, S.G., Yi, J.H., Annex, B.H., Zioncheck, T.F., A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans (2002) Clin. Pharmacol. Ther., 72, pp. 20-32
Stefanini, M.O., Wu, F.T., Mac Gabhann, F., Popel, A.S., A compartment model of VEGF distribution in blood, healthy and diseased tissues (2008) BMC Syst. Biol., 2, p. 77
Vempati, P., Popel, A.S., Mac Gabhann, F., Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning (2014) Cytokine Growth Factor Rev., 25, pp. 1-19
Keyt, B.A., Berleau, L.T., Nguyen, H.V., Chen, H., Heinsohn, H., Vandlen, R., Ferrara, N., The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency (1996) J. Biol. Chem., 271, pp. 7788-7795
Lauer, G., Sollberg, S., Cole, M., Krieg, T., Eming, S.A., Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site (2002) FEBS Lett., 531, pp. 309-313
Thorne, R.G., Pronk, G.J., Padmanabhan, V., Frey, W.H., 2nd, Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration (2004) Neuroscience, 127, pp. 481-496
Yang, J.P., Liu, H.J., Cheng, S.M., Wang, Z.L., Cheng, X., Yu, H.X., Liu, X.F., Direct transport of VEGF from the nasal cavity to brain (2009) Neurosci. Lett., 449, pp. 108-111
Thorne, R.G., Frey, W.H., II, Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations (2001) Clin. Pharmacokinet., 40, pp. 907-946
Gu, F., Amsden, B., Neufeld, R., Sustained delivery of vascular endothelial growth factor with alginate beads (2004) J. Control. Release, 96, pp. 463-472
Lee, K.W., Yoon, J.J., Lee, J.H., Kim, S.Y., Jung, H.J., Kim, S.J., Joh, J.W., Lee, S.K., Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan (2004) Transplant. Proc., 36, pp. 2464-2465
Semete, B., Booysen, L., Lemmer, Y., Kalombo, L., Katata, L., Verschoor, J., Swai, H.S., In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems (2010) Nanomedicine, 6, pp. 662-671
Golub, J.S., Kim, Y.T., Duvall, C.L., Bellamkonda, R.V., Gupta, D., Lin, A.S., Weiss, D., Guldberg, R.E., Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth (2010) Am. J. Physiol. Heart Circ. Physiol., 298, pp. H1959-H1965
Formiga, F.R., Pelacho, B., Garbayo, E., Abizanda, G., Gavira, J.J., Simon-Yarza, T., Mazo, M., Blanco-Prieto, M.J., Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model (2010) J. Control. Release, 147, pp. 30-37
Herrán, E., Pérez-González, R., Igartua, M., Pedraz, J.L., Carro, E., Hernández, R.M., VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease (2013) J., Control,l Release, 170, pp. 111-119
Herran, E., Perez-Gonzalez, R., Igartua, M., Pedraz, J.L., Carro, E., Hernandez, R.M., Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer's Disease After Implantation of VEGF-loaded PLGA Nanospheres (2015) Curr. Alzheimer Res., 12, pp. 932-940
Herrán, E., Ruiz-Ortega, J.Á., Aristieta, A., Igartua, M., Requejo, C., Lafuente, J.V., Ugedo, L., Hernández, R.M., In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease (2013) Eur. J. Pharm. Biopharm., 85 (3), pp. 1183-1190
Herrán, E., Requejo, C., Ruiz-Ortega, J.A., Aristieta, A., Igartua, M., Bengoetxea, H., Ugedo, L., Hernández, R.M., Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease (2014) Int. J. Nanomed., 9, pp. 2677-2687
Ju, R., Wen, Y., Gou, R., Wang, Y., Xu, Q., The experimental therapy on brain ischemia by improvement of local angiogenesis with tissue engineering in the mouse (2014) Cell Transplant., 23, pp. S83-S95
Zhu, J., Jiang, Y., Xu, G., Liu, X., Intranasal administration: a potential solution for cross-BBB delivering neurotrophic factors (2012) Histol. Histopathol., 27, pp. 537-548
Andrade, C., Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression (2015) J. Clin. Psychiatry, 76, pp. 628-631
Derry, C.J., Derry, S., Moore, R.A., Sumatriptan (intranasal route of administration) for acute migraine attacks in adults (2012) Cochrane Database Syst. Rev., 2
Dietrich, E., Gums, J.G., Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain (2012) Ann. Pharmacother., 46, pp. 1382-1391
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.J., Le Guen, M., Devillier, P., Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids (2012) Pharmacol. Ther., 134, pp. 366-379
Kerr, D., Dietze, P., Kelly, A.M., Intranasal naloxone for the treatment of suspected heroin overdose (2008) Addiction, 103, pp. 379-386
Kronenberg, R.H., Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration (2002) J. Pain Palliat. Care Pharmacother., 16, pp. 27-35
Murphy, A., O'Sullivan, R., Wakai, A., Grant, T.S., Barrett, M.J., Cronin, J., McCoy, S.C., Kandamany, N., Intranasal fentanyl for the management of acute pain in children (2014) Cochrane Database Syst. Rev., 10. , (CD009942)
Pires, A., Fortuna, A., Alves, G., Falcão, A., Intranasal drug delivery: how, why and what for? (2009) J. Pharm. Pharm. Sci., 12, pp. 288-311
Rapoport, A.M., Bigal, M.E., Tepper, S.J., Sheftell, F.D., Intranasal medications for the treatment of migraine and cluster headache (2004) CNS Drugs, 18, pp. 671-685
Robinson, A., Wermeling, D.P., Intranasal naloxone administration for treatment of opioid overdose (2014) Am. J. Health Syst. Pharm., 71, pp. 2129-2135
Santangelo, B., Micieli, F., Marino, F., Reynaud, F., Cassandro, P., Carfora, A., Petrella, R., Vesce, G., Plasma concentrations and sedative effects of a dexmedetomidine, midazolam, and butorphanol combination after transnasal administration in healthy rabbits (2016) J. Vet. Pharm. Ther., 39, pp. 408-411
Sibley, T., Jacobsen, R., Salomone, J., Successful administration of intranasal glucagon in the out-of-hospital environment (2013) Prehosp. Emerg. Care, 17, pp. 98-102
Wolfe, T.R., Bernstone, T., Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases (2004) J. Emerg. Nurs., 30, pp. 141-147
Guardia Clausi, M., Paez, P.M., Pasquini, L.A., Pasquini, J.M., Inhalation of growth factors and apo-transferrin to protect and repair the hypoxic-ischemic brain (2016) Pharmacol. Res., 109, pp. 81-85
Graff, C.L., Pollack, G.M., Nasal drug administration: potential for targeted central nervous system delivery (2005) J. Pharm. Sci., 94, pp. 1187-1195
Tayebati, S.K., Nwankwo, I.E., Amenta, F., Intranasal drug delivery to the central nervous system: present status and future outlook (2013) Curr. Pharm. Des., 19, pp. 510-526
Spetter, M.S., Hallschmid, M., Intranasal neuropeptide administration to target the human brain in health and disease (2015) Mol. Pharm., 12 (8), pp. 2767-2780
Sun, J., Wei, Z.Z., Gu, X., Zhang, J.Y., Zhang, Y., Li, J., Wei, L., Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice (2015) Exp. Neurol., 272, pp. 78-87
Zhao, Q., Hu, J., Xiang, J., Gu, Y., Jin, P., Hua, F., Zhang, Z., Ye, X., Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke (1624) Brain Res., 2015, pp. 489-496
Illum, L., Transpot of drugs from the nasal cavity to the central nervous system (2000) Eur. J. Pharm. Sci., 11, pp. 1-18
Kapoor, M., Cloyd, J.C., Siegel, R.A., A review of intranasal formulations for the treatment of seizure emergencies (2016) J. Control Release, 237, pp. 147-159
Matsune, S., Ohori, J., Yoshifuku, K., Kurono, Y., Effect of vascular endothelial growth factor on nasal vascular permeability (2010) Laryngoscope, 120, pp. 844-848
Henry, T., Annex, B., Azrin, M., Double blind placebo controlled trial of recombinant human vascular endothelial growth factor: the VIVA trial (1999) J. Am. Coll. Cardiol., 33, p. 384A. , (Abstract)
Laham, R.J., Sellke, F.W., Edelman, E.R., Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial (1999) Circulation, 100, pp. 1865-1871
Laitinen, M., Hartikainen, J., Hiltunen, M.O., Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty (2000) Hum. Gene Ther., 11, pp. 263-270
Losordo, D.W., Vale, P.R., Symes, J.F., Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia (1998) Circulation, 98, pp. 2800-2804
Rosengart, T.K., Lee, L.Y., Patel, S.R., Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease (1999) Circulation, 100, pp. 468-474
Schumacher, B., Pecher, P., von Specht, B., Induction of neoangiogenesis in ischemic myocardium by human growth factors (1998) Circulation, 97, pp. 645-650
Springer, M.L., Chen, A.S., Kraft, P.E., Bednarski, M., Blau, H.M., VEGF gene delivery to muscle: potential role for vasculogenesis in adults (1998) Mol. Cell, 2, pp. 549-558
Lee, R.J., Springer, M.L., Blanco-Bose, W.E., Shaw, R., Ursell, P.C., Blau, H.M., VEGF gene delivery to myocardium: deleterious effects of unregulated expression (2000) Circulation, 102, pp. 898-901
Pettersson, A., Nagy, J.A., Brown, L.F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Harvey, V.S., Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor (2000) Lab. Investig., 80, pp. 99-115
Sundberg, C., Nagy, J.A., Brown, L.F., Feng, D., Eckelhoefer, I.A., Manseau, E.J., Dvorak, A.M., Dvorak, H.F., Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery (2001) Am. J. Pathol., 158, pp. 1145-1160
Schwarz, E.R., Speakman, M.T., Patterson, M., Hale, S.S., Isner, J.M., Kedes, L.H., Kloner, R.A., Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat: angiogenesis and angioma formation (2000) J. Am. Coll. Cardiol., 35, pp. 1323-1330
Chen, B., Friedman, B., Cheng, Q., Tsai, P., Schim, E., Kleinfeld, D., Lyden, P.D., Severe blood-brain barrier disruption and surrounding tissue injury (2009) Stroke, 40, pp. e666-e674
Keaney, J., Campbell, M., The dynamic blood-brain barrier (2015) FEBS J., 282, pp. 4067-4079
Montagne, A., Nation, D.A., Pa, J., Sweeney, M.D., Toga, A.W., Zlokovic, B.V., Brain imaging of neurovascular dysfunction in Alzheimer's disease (2016) Acta Neuropathol., 131, pp. 687-707
Popescu, B.O., Toescu, E.C., Popescu, L.M., Bajenaru, O., Muresanu, D.F., Schultzberg, M., Bogdanovic, N., Blood-brain barrier alterations in ageing and dementia (2009) J. Neurol. Sci., 283, pp. 99-106
Prakash, R., Carmichael, S.T., Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury (2015) Curr. Opin. Neurol., 28, pp. 556-564
Stolp, H.B., Dziegielewska, K.M., Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases (2009) Neuropathol. Appl. Neurobiol., 35, pp. 132-146
Ueno, M., Chiba, Y., Matsumoto, K., Murakami, R., Fujihara, R., Kawauchi, M., Miyanaka, H., Nakagawa, T., Blood-brain barrier damage in vascular dementia (2016) Neuropathology, 36, pp. 115-124
Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders (2011) Nat. Rev. Neurosci., 12, pp. 723-738
Zlokovic, B.V., The blood-brain barrier in health and chronic neurodegenerative disorders (2008) Neuron, 57, pp. 178-201
Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., Dvorak, H.F., Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid (1983) Science, 219, pp. 983-985
Horowitz, A., Seerapu, H.R., Regulation of VEGF signaling by membrane traffic (2012) Cell Signal., 24, pp. 1810-1820
Nakayama, M., Berger, P., Coordination of VEGF receptor trafficking and signaling by coreceptors (2013) Exp. Cell Res., 319, pp. 1340-1347
Argaw, A.T., Gurfein, B.T., Zhang, Y., Zameer, A., John, G.R., VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown (2009) Proc. Natl. Acad. Sci. USA, 106, pp. 1977-1982
Fischer, S., Wobben, M., Marti, H.H., Renz, D., Schaper, W., Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1 (2002) Microvasc. Res., 63, pp. 70-80
Ghassemifar, R., Lai, C.M., Rakoczy, P.E., VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells (2006) Cell Tissue Res, 323, pp. 117-125
Wang, W., Dentler, W.L., Borchardt, R.T., VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly (2001) Am. J. Physiol. Heart Circ. Physiol., 280, pp. H434-H440
Argaw, A.T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J.N., Mahase, S., John, G.R., Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease (2012) J. Clin. Investig., 122, pp. 2454-2468
Suzuki, Y., Nagai, N., Yamakawa, K., Muranaka, Y., Hokamura, K., Umemura, K., Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice (2015) J. Cereb. Blood Flow. Metab., 35, pp. 2021-2031
Kanazawa, M., Igarashi, H., Kawamura, K., Takahashi, T., Kakita, A., Takahashi, H., Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment (2011) J. Cereb. Blood Flow. Metab., 31, pp. 1461-1474
Reeson, P., Tennant, K.A., Gerrow, K., Wang, J., Weiser Novak, S., Thompson, K., Lockhart, K.L., Brown, C.E., Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner (2015) J. Neurosci., 35, pp. 5128-5143
Lee, I.L., Li, P.S., Yu, W.L., Shen, H.H., Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited (2011) Protein Expr. Purif., 76, pp. 54-58
Cohen, T., Gitay-Goren, H., Neufeld, G., Levi, B.Z., High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system (1992) Growth Factors, 7, pp. 131-138
Pizarro, S.A., Gunson, J., Field, M.J., Dinges, R., Khoo, S., Dalal, M., Lee, M., Schmelzer, C.H., High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications (2010) Protein Expr. Purif., 72, pp. 184-193
Scheidegger, P., Weiglhofer, W., Suarez, S., Kaser-Hotz, B., Steiner, R., Ballmer-Hofer, K., Jaussi, R., Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs (1999) Biol. Chem., 380, pp. 1449-1454
Mandal, K., Kent, S.B., Total chemical synthesis of biologically active vascular endothelial growth factor (2011) Angew. Chem. Int. Ed. Engl., 50, pp. 8029-8033
Bae, D.G., Kim, T.D., Li, G., Yoon, W.H., Chae, C.B., Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis (2005) Clin. Cancer Res., 11, pp. 2651-2661
Basile, A., Del Gatto, A., Diana, D., Di Stasi, R., Falco, A., Festa, M., Rosati, A., D'Andrea, L.D., Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo (2011) J. Med. Chem., 54, pp. 1391-1400
Foy, K.C., Liu, Z., Phillips, G., Miller, M., Kaumaya, P.T., Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo (2011) J. Biol. Chem., 286, pp. 13626-13637
Rastelli, L., Valentino, M.L., Minderman, M.C., Landin, J., Malyankar, U.M., Lescoe, M.K., Kitson, R., Rabbani, S.A., A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo (2011) Int. J. Oncol., 39, pp. 401-408
Vicari, D., Foy, K.C., Liotta, E.M., Kaumaya, P.T., Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways (2011) J. Biol. Chem., 286, pp. 13612-13625
D'Andrea, L.D., Del Gatto, A., De Rosa, L., Romanelli, A., Pedone, C., Peptides targeting angiogenesis related growth factor receptors (2009) Curr. Pharm. Des., 15, pp. 2414-2429
D'Andrea, L.D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Trimarco, B., Pedone, C., Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 14215-14220
Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., de Vos, A.M., Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor (1997) Cell, 91, pp. 695-704
Diana, D., Ziaco, B., Colombo, G., Scarabelli, G., Romanelli, A., Pedone, C., Fattorusso, R., D'Andrea, L.D., Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide (2008) Chemistry, 14, pp. 4164-4166
Ziaco, B., Diana, D., Capasso, D., Palumbo, R., Celentano, V., Di Stasi, R., Fattorusso, R., D'Andrea, L.D., C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties (2012) Biochem. Biophys. Res. Commun., 424, pp. 290-294
Finetti, F., Basile, A., Capasso, D., Di Gaetano, S., Di Stasi, R., Pascale, M., Turco, C.M., D'Andrea, L.D., Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis (2012) Biochem. Pharmacol., 84, pp. 303-311
Santulli, G., Ciccarelli, M., Palumbo, G., Campanile, A., Galasso, G., Ziaco, B., Altobelli, G.G., Iaccarino, G., In vivo properties of the proangiogenic peptide QK (2009) J. Transl. Med., 7, p. 41
Dudar, G.K., D'Andrea, L.D., Di Stasi, R., Pedone, C., Wallace, J.L., A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner (2008) Am. J. Physiol. Gastrointest. Liver Physiol., 295, pp. G374-G381
Verheyen, A., Peeraer, E., Lambrechts, D., Poesen, K., Carmeliet, P., Shibuya, M., Pintelon, I., Meert, T., Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies (2013) Neuroscience, 244, pp. 77-89
Chan, T.R., Stahl, P.J., Yu, S.M., Matrix-Bound VEGF Mimetic Peptides: design and Endothelial Cell Activation in Collagen Scaffolds (2011) Adv. Funct. Mater., 21, pp. 4252-4262
Kumar, V.A., Taylor, N.L., Shi, S., Wang, B.K., Jalan, A.A., Kang, M.K., Wickremasinghe, N.C., Hartgerink, J.D., Highly angiogenic peptide nanofibers (2015) ACS Nano, 9, pp. 860-868
Lee, J.S., Wagoner Johnson, A.J., Murphy, W.L., A modular, hydroxyapatite-binding version of vascular endothelial growth factor (2010) Adv. Mater., 22, pp. 5494-5498
Leslie-Barbick, J.E., Saik, J.E., Gould, D.J., Dickinson, M.E., West, J.L., The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide (2011) Biomaterials, 32, pp. 5782-5789
Liu, X., Wang, X., Horii, A., Wang, X., Qiao, L., Zhang, S., Cui, F.Z., In vivo studies on angiogenic activity of two designer self-assembling peptide scaffold hydrogels in the chicken embryo chorioallantoic membrane (2012) Nanoscale, 4, pp. 2720-2727
Mulyasasmita, W., Cai, L., Hori, Y., Heilshorn, S.C., Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels (2014) Tissue Eng. Part A., 20, pp. 2102-2114
Stahl, P.J., Chan, T.R., Shen, Y.I., Sun, G., Gerecht, S., Yu, S.M., Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization (2014) Adv. Funct. Mater., 24, pp. 3213-3225
Suárez-González, D., Barnhart, K., Migneco, F., Flanagan, C., Hollister, S.J., Murphy, W.L., Controllable mineral coatings on PCL scaffolds as carriers for growth factor release (2012) Biomaterials, 33, pp. 713-721
Webber, M.J., Tongers, J., Newcomb, C.J., Marquardt, K.T., Bauersachs, J., Losordo, D.W., Stupp, S.I., Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair (2011) Proc. Natl. Acad. Sci. USA, 108, pp. 13438-13443
Pignataro, G., Ziaco, B., Tortiglione, A., Gala, R., Cuomo, O., Vinciguerra, A., Lapi, D., Cataldi, M., Neuroprotective effect of vegf-mimetic peptide qk in experimental brain ischemia induced in rat by middle cerebralartery occlusion (2015) ACS Chem. Neurosci., 6, pp. 1517-1525
Zhang, Y., Furumura, M., Morita, E., Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165 (2008) Growth Factors, 26, pp. 125-131
Diana, D., Basile, A., De Rosa, L., Di Stasi, R., Auriemma, S., Arra, C., Pedone, C., D'Andrea, L.D., β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity (2011) J. Biol. Chem., 286, pp. 41680-41691
Diana, D., De Rosa, L., Palmieri, M., Russomanno, A., Russo, L., La Rosa, C., Milardi, D., Fattorusso, R., Long range Trp-Trp interaction initiates the folding pathway of a pro-angiogenic β-hairpin peptide (2015) Sci. Rep., 5, p. 16651
Di Stasi, R., Diana, D., Capasso, D., Palumbo, R., Romanelli, A., Pedone, C., Fattorusso, R., D'Andrea, L.D., VEGFR1(D2) in drug discovery: expression and molecular characterization (2010) Biopolymers, 94 (6), pp. 800-809
Diana, D., Russomanno, A., De Rosa, L., Di Stasi, R., Capasso, D., Di Gaetano, S., Romanelli, A., Fattorusso, R., Functional binding surface of a β-hairpin VEGF receptor targeting peptide determined by NMR spectroscopy in living cells (2015) Chemistry, 21, pp. 91-95
De Rosa, L., Finetti, F., Diana, D., Di Stasi, R., Auriemma, S., Romanelli, A., Fattorusso, R., D'Andrea, L.D., Miniaturizing VEGF: peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response (2016) Sci. Rep., 6, p. 31295
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 0, 5-year impact factor: 0
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012254796&doi=10.1016%2fj.nhtm.2016.12.002&partnerID=40&md5=c0d02f11f1e9548529414a6ed55138fd
Keywords: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Epilepsy, Intranasal Administration, Neurodegeneration, Parkinson, S Disease, Qk Peptide, Stroke, Vegf, Vasculotropin, Untranslated Region, Brain Disease, Central Nervous System, Cerebrovascular Accident, Crystal Structure, Crystallography, Genetic Polymorphism, Genetic Transcription, Human, Nerve Regeneration, Neuroprotection, Parkinson Disease, Priority Journal, Protein Expression, Protein Phosphorylation, Review, Tissue Repair,
Affiliations:
*** IBB - CNR ***
Institute of Biostructure and Bioimaging, National Research Council, Naples, Italy
Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatologic Sciences, Federico II University of Naples, Italy
References:
Baumgartner, I., Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor (2000) Curr. Cardiol. Rep., 2, pp. 24-2
Hendel, R.C., Henry, T.D., Rocha-Singh, K., Isner, J.M., Kereiakes, D.J., Giordano, F.J., Simons, M., Bonow, R.O., Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect (2000) Circulation, 101, pp. 118-121
Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., McCluskey, E.R., VIVA Investigators, The VIVA trial: vascular endothelial growth factor in Ischemia for vascular angiogenesis (2003) Circulation, 107, pp. 1359-1365
Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Isner, J.M., Therapeutic angiogenesis. a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model (1994) J. Clin. Invest., 93, pp. 662-670
Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., Carmeliet, P., Role and therapeutic potential of VEGF in the nervous system (2009) Physiol. Rev., 89, pp. 607-648
Lange, C., Storkebaum, E., de Almodóvar, C.R., Dewerchin, M., Carmeliet, P., Vascular endothelial growth factor: a neurovascular target in neurological diseases (2016) Nat. Rev. Neurol., 12, pp. 439-454
Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J., Ferrara, N., Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms (1992) J. Biol. Chem., 267, pp. 26031-26037
Park, J.E., Keller, G.A., Ferrara, N., The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF (1993) Mol. Biol. Cell., 4, pp. 1317-1326
Ortéga, N., L'Faqihi, F.E., Plouët, J., Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix (1998) Biol. Cell., 90, pp. 381-390
Amin, E.M., Oltean, S., Hua, J., Gammons, M.V., Hamdollah-Zadeh, M., Welsh, G.I., Cheung, M.K., Ladomery, M.R., WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing (2011) Cancer Cell., 20, pp. 768-780
Eswarappa, S.M., Potdar, A.A., Koch, W.J., Fan, Y., Vasu, K., Lindner, D., Willard, B., Fox, P.L., Programmed translational readthrough generates antiangiogenic VEGF-Ax (2014) Cell, 157, pp. 1605-1618
Harris, S., Craze, M., Newton, J., Fisher, M., Shima, D.T., Tozer, G.M., Kanthou, C., Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale (2012) PLoS One, 7, p. e35231
Xin, H., Zhong, C., Nudleman, E., Ferrara, N., Evidence for Pro-angiogenic Functions of VEGF-Ax (2016) Cell, 167, pp. 275-284
Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C., de Vos, A.M., Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 7192-7197
Muller, Y.A., Christinger, H.W., Keyt, B.A., de Vos, A.M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338
Ferrara, N., Gerber, H.P., LeCouter, J., The biology of VEGF and its receptors (2003) Nat. Med., 9, pp. 669-676
Cao, Y., Positive and negative modulation of angiogenesis by VEGFR1 ligands.Sci (2009) Signal, 2. , (re1)
Cross, M.J., Dixelius, J., Matsumoto, T., Claesson-Welsh, L., VEGF-receptor signal transduction (2003) Trends Biochem. Sci., 28, pp. 488-494
Shibuya, M., Claesson-Welsh, L., Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis (2006) Exp. Cell. Res., 312, pp. 549-560
Olsson, A.K., Dimberg, A., Kreuger, J., Claesson-Welsh, L., VEGF receptor signalling in control of vascular function (2006) Nat. Rev. Mol. Cell. Biol., 7, pp. 359-371
Gélinas, D.S., Bernatchez, P.N., Rollin, S., Bazan, N.G., Sirois, M.G., Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways (2002) Br. J. Pharmacol., 137, pp. 1021-1030
Rosenstein, J.M., Krum, J.M., Ruhrberg, C., VEGF in the nervous system (2010) Organogenesis, 6, pp. 107-114
Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L., Greenberg, D.A., Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 11946-11950
Licht, T., Keshet, E., Delineating multiple functions of VEGF-A in the adult brain (2013) Cell. Mol. Life Sci., 70, pp. 1727-1737
Carmeliet, P., Ruiz de Almodovar, C., VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration (2013) Cell. Mol. Life Sci., 70, pp. 1763-1778
Jin, K., Mao, X.O., Batteur, S.P., McEachron, E., Leahy, A., Greenberg, D.A., Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor (2001) Neuroscience, 108, pp. 351-358
Jin, K.L., Mao, X.O., Greenberg, D.A., Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 10242-10247
Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N., Tohyama, M., Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades (2001) FASEB J., 15, pp. 1218-1220
Svensson, B., Peters, M., König, H.G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Prehn, J.H., Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism (2002) J. Cereb. Blood Flow. Metab., 22, pp. 1170-1175
Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., Ferrara, N., Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation (1998) J. Biol. Chem., 273, pp. 30336-30343
Yu, S., Liu, Y.P., Liu, Y.H., Jiao, S.S., Liu, L., Wang, Y.J., Fu, W.L., Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients (2016) Clin. Chim. Acta, 453, pp. 154-159
Yu, S.P., Farhangrazi, Z.S., Ying, H.S., Yeh, C.H., Choi, D.W., Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death (1998) Neurobiol. Dis., 5, pp. 81-88
Xu JY, J.Y., Zheng, P., Shen, D.H., Yang, S.Z., Zhang, L.M., Huang, Y.L., Sun, F.Y., Vascular endothelial growth factor inhibits outward delayed-rectifier potassium currents in acutely isolated hippocampal neurons (2003) Neuroscience, 118, pp. 59-67
Qiu, M.H., Zhang, R., Sun, F.Y., Enhancement of ischemia-induced tyrosine phosphorylation of Kv1.2 by vascular endothelial growth factor via activation of phosphatidylinositol 3-kinase (2003) J. Neurochem., 87, pp. 1509-1517
Huang, X.Y., Morielli, A.D., Peralta, E.G., Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor (1993) Cell, 75, pp. 1145-1156
Wu, K.W., Yang, P., Li, S.S., Liu, C.W., Sun, F.Y., VEGF attenuated increase of outward delayed-rectifier potassium currents in hippocampal neurons induced by focal ischemia via PI3-K pathway (2015) Neuroscience, 298, pp. 94-101
Ma, Y.Y., Li, K.Y., Wang, J.J., Huang, Y.L., Huang, Y., Sun, F.Y., Vascular endothelial growth factor acutely reduces calcium influx via inhibition of the Ca2+ channels in rat hippocampal neurons (2009) J. Neurosci. Res., 87, pp. 393-402
Kim, B.W., Choi, M., Kim, Y.S., Park, H., Lee, H.R., Yun, C.O., Kim, E.J., Son, H., Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin (2008) Cell. Signal, 20, pp. 714-725
Sun, G.C., Ma, Y.Y., Vascular endothelial growth factor modulates voltage-gated Na+channel properties and depresses action potential firing in cultured rat hippocampal neurons (2013) Biol. Pharm. Bull., 36, pp. 548-555
Palmer, T.D., Willhoite, A.R., Gage, F.H., Vascular niche for adult hippocampal neurogenesis (2000) J. Comp. Neurol., 425, pp. 479-494
Ward, N.L., Lamanna, J.C., The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems (2004) Neurol. Res., 26, pp. 870-883
Font, M.A., Arboix, A., Krupinski, J., Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke (2010) Curr. Cardiol. Rev., 6, pp. 238-244
Greenberg, D.A., Jin, K., Vascular endothelial growth factors (VEGFs) and stroke (2013) Cell. Mol. Life Sci., 70, pp. 1753-1761
Madri, J.A., Modeling the neurovascular niche: implications for recovery from CNS injury (2009) J. Physiol. Pharmacol., 60, pp. 95-104
Ohab, J.J., Fleming, S., Blesch, A., Carmichael, S.T., A neurovascular niche for neurogenesis after stroke (2006) J. Neurosci., 26, pp. 13007-13016
Zhang, R.L., Chopp, M., Roberts, C., Liu, X., Wei, M., Nejad-Davarani, S.P., Wang, X., Zhang, Z.G., Stroke increases neural stem cells and angiogenesis in the neurogenic niche of the adult mouse (2014) PLoS One, 9, p. e113972
Brumm, A.J., Carmichael, S.T., Not just a rush of blood to the head (2012) Nat. Med., 18, pp. 1609-1610
Muramatsu, R., Takahashi, C., Miyake, S., Fujimura, H., Mochizuki, H., Yamashita, T., Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin (2012) Nat. Med., 18, pp. 1658-1664
Hermann, D.M., Zechariah, A., Implications of vascular endothelial growth factor for postischemic neurovascular remodeling (2009) J. Cereb. Blood Flow. Metab., 29, pp. 1620-1643
Ma, Y., Zechariah, A., Qu, Y., Hermann, D.M., Effects of vascular endothelial growth factor in ischemic stroke (2012) J. Neurosci. Res., 90, pp. 1873-1882
Schmidt, N.O., Przylecki, W., Yang, W., Ziu, M., Teng, Y., Kim, S.U., Black, P.M., Carroll, R.S., Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor (2005) Neoplasia, 7, pp. 623-629
Schmidt, N.O., Koeder, D., Messing, M., Mueller, F.J., Aboody, K.S., Kim, S.U., Black, P.M., Lamszus, K., Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche (2009) Brain Res., 1268, pp. 24-37
LaManna, J.C., Kuo, N.T., Lust, W.D., Hypoxia-induced brain angiogenesis. Signals and consequences (1998) Adv. Exp. Med. Biol., 454, pp. 287-293
Marti, H.J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., Risau, W., Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia (2000) Am. J. Pathol., 156, pp. 965-976
Szade, A., Grochot-Przeczek, A., Florczyk, U., Jozkowicz, A., Dulak, J., Cellular and molecular mechanisms of inflammation-induced angiogenesis (2015) IUBMB Life, 67, pp. 145-159
Caruana, M., Cauchi, R., Vassallo, N., Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease (2016) Front. Nutr., 3, p. 31
Mandel, S.A., Weinreb, O., Amit, T., Youdim, M.B., Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols (2012), pp. 4581-598. , Front. Biosci. (Schol Ed)
Pérez-Hernández, J., Zaldívar-Machorro, V.J., Villanueva-Porras, D., Vega-Ávila, E., Chavarría, A., A Potential alternative against neurodegenerative diseases: phytodrugs (2016) Oxid. Med. Cell Longev., 2016, p. 8378613
Ajami, M., Pazoki-Toroudi, H., Amani, H., Nabavi, S.F., Braidy, N., Vacca, R.A., Atanasov, A.G., Nabavi, S.M., Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols (2016) Neurosci. Biobehav. Rev., , (Epub ahead of print)
Donà, M., Dell'Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A., Garbisa, S., Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis (2003) J. Immunol., 170, pp. 4335-4341
Malhotra, S., Tavakkoli, M., Edraki, N., Miri, R., Sharma, S.K., Prasad, A.K., Saso, L., Firuzi, O., Neuroprotective and antioxidant activities of 4-methylcoumarins: development of structure-activity relationships (2016) Biol. Pharm. Bull., 39, pp. 1544-1548
Lapi, D., Vagnani, S., Pignataro, G., Esposito, E., Paterni, M., Colantuoni, A., Protective Effects of Quercetin on Rat Pial Microvascular Changes during Transient Bilateral Common Carotid Artery Occlusion and Reperfusion (2012) Front. Physiol., 3, p. 32
Albini, A., Tosetti, F., Li, V.W., Noonan, D.M., Li, W.W., Cancer prevention by targeting angiogenesis (2012) Nat. Rev. Clin. Oncol., 9, pp. 498-509
Benelli, R., Venè, R., Bisacchi, D., Garbisa, S., Albini, A., Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases (2002) Biol. Chem., 383, pp. 101-105
Fernando, W., Rupasinghe, H.P., Hoskin, D.W., Regulation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling by plant flavonoids (2015) Mini Rev. Med. Chem., 15, pp. 479-489
Fu, B., Xue, J., Li, Z., Shi, X., Jiang, B.H., Fang, J., Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis (2007) Mol. Cancer Ther., 6, pp. 220-226
Gallo, C., Dallaglio, K., Bassani, B., Rossi, T., Rossello, A., Noonan, D.M., D'Uva, G., Albini, A., Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation (2016) Oncotarget, , (Epub ahead of print)
García-Maceira, P., Mateo, J., Silibinin inhibits hypoxia-inducible factor−1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy (2009) Oncogene, 28, pp. 313-324
Jeon, H., Kim, H., Choi, D., Kim, D., Park, S.Y., Kim, Y.J., Kim, Y.M., Jung, Y., Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase (2007) Mol. Pharmacol., 71, pp. 1676-1684
Zhou, Y.D., Kim, Y.P., Li, X.C., Baerson, S.R., Agarwal, A.K., Hodges, T.W., Ferreira, D., Nagle, D.G., Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts (2004) J. Nat. Prod., 67, pp. 2063-2069
Thomas, R., Kim, M.H., Epigallocatechin gallate inhibits HIF-1a degradation in prostate cancer cells (2005) Biochem. Biophys. Res. Commun., 334, pp. 543-548
Amoroso, S., Gioielli, A., Cataldi, M., Di Renzo, G., Annunziato, L., In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca2+ increase (1999) Biochim. Biophys. Acta, 1452, pp. 151-160
Annunziato, L., Pannaccione, A., Cataldi, M., Secondo, A., Castaldo, P., Renzo, G.D., Taglialatela, M., Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? (2002) Neurobiol. Aging, 23, pp. 819-834
Annunziato, L., Cataldi, M., Pignataro, G., Secondo, A., Molinaro, P., Glutamate-independent calcium toxicity: introduction (2007) Stroke, 38 (2), pp. S661-S664
Zacchigna, S., Lambrechts, D., Carmeliet, P., Neurovascular signalling defects in neurodegeneration (2008) Nat. Rev. Neurosci., 9, pp. 169-181
Hansen, T.M., Moss, A.J., Brindle, N.P., Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke (2008) Curr. Neurovasc. Res., 5, pp. 236-245
Nowacka, M.M., Obuchowicz, E., Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action (2012) Neuropeptides, 46, pp. 1-10
Zachary, I., Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential (2005) Neurosignals, 14, pp. 207-221
Beck, H., Plate, K.H., Angiogenesis after cerebral ischemia (2009) Acta Neuropathol., 117, pp. 481-496
Kovács, Z., Ikezaki, K., Samoto, K., Inamura, T., Fukui, M., VEGF and flt (1996) Expr. Time Kinet. Rat. brain Infarct. Stroke, 27, pp. 1865-1872
Hayashi, T., Abe, K., Suzuki, H., Itoyama, Y., Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats (1997) Stroke, 28, pp. 2039-2044
Lee, M.Y., Ju, W.K., Cha, J.H., Son, B.C., Chun, M.H., Kang, J.K., Park, C.K., Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats (1999) Neurosci. Lett., 265, pp. 107-110
Hai, J., Li, S.T., Lin, Q., Pan, Q.G., Gao, F., Ding, M.X., Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain (2003) Neurosurgery, 53, pp. 963-970
Yang, J., Yao, Y., Chen, T., Zhang, T., VEGF ameliorates cognitive impairment in vivo and in vitro ischemia via improving neuronal viability and function (2014) Neuromol. Med., 16, pp. 376-388
Yang, Z.J., Bao, W.L., Qiu, M.H., Zhang, L.M., Lu, S.D., Huang, Y.L., Sun, F.Y., Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia (2002) J. Neurosci. Res., 70, pp. 140-149
Bao, W.L., Lu, S.D., Wang, H., Sun, F.Y., Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia (1999) Zhongguo Yao Li Xue Bao, 20, pp. 313-318
Shimotake, J., Derugin, N., Wendland, M., Vexler, Z.S., Ferriero, D.M., Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke (2010) Stroke, 41, pp. 343-349
Whitaker, V.R., Cui, L., Miller, S., Yu, S.P., Wei, L., Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice (2007) J. Cereb. Blood Flow. Metab., 27, pp. 57-68
Li, W.L., Fraser, J.L., Yu, S.P., Zhu, J., Jiang, Y.J., Wei, L., The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice (2011) Exp. Brain Res., 214, pp. 503-513
Qiu, S., Wu, T., Wang, P., Li, J., Li, Q., Du, J., The association between VEGFR gene polymorphisms and stroke: a meta-analysis (2016) PLoS One, 11, p. e0151371
Wu, T., Qiu, S., Wang, P., Li, J., Li, Q., Du, J., The association between vascular endothelial growth factor gene polymorphisms and stroke: a meta-analysis (2016) Brain Behav., 6, p. e00482
Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N.V., Chopp, M., VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain (2000) J. Clin. Invest., 106, pp. 829-838
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., Greenberg, D.A., VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia (2003) J. Clin. Invest., 111, pp. 1843-1851
Harrigan, M., Ennis, S., Masada, T., Keep, R., Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema (2002) Neurosurgery, 50, pp. 589-598
Harrigan, M.R., Ennis, S.R., Sullivan, S.E., Keep, R.F., Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume (2003) Acta Neurochir. (Wien.)., 145, pp. 49-53
Manoonkitiwongsa, P.S., Schultz, R.L., McCreery, D.B., Whitter, E.F., Lyden, P.D., Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis (2004) J. Cereb. Blood Flow. Metab., 24, pp. 693-702
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Carmeliet, P., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration (2001) Nat. Genet., 28, pp. 131-138
Green, S.L., Tolwani, R.J., Animal models for motor neuron disease (1999) Lab. Anim. Sci., 49, pp. 480-487
Shefner, J.M., Reaume, A.G., Flood, D.G., Scott, R.W., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Brown, R.H., Jr., Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy (1999) Neurology, 53, pp. 1239-1246
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., Wyns, S., Carmeliet, P., VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (2003) Nat. Genet., 34, pp. 383-394
Lunn, J.S., Sakowski, S.A., Kim, B., Rosenberg, A.A., Feldman, E.L., Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration (2009) Dev. Neurobiol., 69, pp. 871-884
Miyazaki, K., Masamoto, K., Morimoto, N., Kurata, T., Mimoto, T., Obata, T., Kanno, I., Abe, K., Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice (2011) J. Cereb. Blood Flow Metab., 32, pp. 456-467
Sato, K., Morimoto, N., Kurata, T., Mimoto, T., Miyazaki, K., Ikeda, Y., Abe, K., Impaired response of hypoxic sensor protein HIF-1α and its downstream proteins in the spinal motor neurons of ALS model mice (2012) Brain Res., 1473, pp. 55-62
Li, X., Lu, L., Bush, D.J., Zhang, X., Zheng, L., Suswam, E.A., King, P.H., Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region (2009) J. Neurochem., 108, pp. 1032-1044
Lu, L., Zheng, L., Viera, L., Suswam, E., Li, Y., Li, X., Estévez, A.G., King, P.H., Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression (2007) J. Neurosci., 27, pp. 7929-7938
Vijayalakshmi, K., Ostwal, P., Sumitha, R., Shruthi, S., Varghese, A.M., Mishra, P., Manohari, S.G., Alladi, P.A., Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line (2015) Mol. Neurobiol., 51, pp. 995-1007
Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.P., Appelmans, S., Oh, H., Van Damme, P., Carmeliet, P., Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS (2005) Nat. Neurosci., 8, pp. 85-92
Azzouz, M., Ralph, G.S., Storkebaum, E., Walmsley, L.E., Mitrophanous, K.A., Kingsman, S.M., Carmeliet, P., Mazarakis, N.D., VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model (2004) Nature, 429, pp. 413-417
Bogaert, E., Van Damme, P., Poesen, K., Dhondt, J., Hersmus, N., Kiraly, D., Scheveneels, W., Van Den Bosch, L., VEGF protects motor neurons against excitotoxicity by upregulation of GluR2 (2010) Neurobiol. Aging, 31, pp. 2185-2191
Bridges, R.J., Stevens, D.R., Kahle, J.S., Nunn, P.B., Kadri, M., Cotman, C.W., Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-L-ODAP is a selective non-NMDA agonist (1989) J. Neurosci., 9, pp. 2073-2079
Chase, R.A., Pearson, S., Nunn, P.B., Lantos, P.L., Comparative toxicities of alpha- and beta-N-oxalyl-L-alpha, beta-diaminopropionic acids to rat spinal cord (1985) Neurosci. Lett., 55, pp. 89-94
Spencer, P.S., Roy, D.N., Ludolph, A., Hugon, J., Dwivedi, M.P., Schaumburg, H.H., Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA (1986) Lancet, 2-8515, pp. 1066-1067
Hugon, J., Ludolph, A., Roy, D.N., Schaumburg, H.H., Spencer, P.S., Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus and IDPN (1988) Neurology, 38, pp. 435-442
Devos, D., Moreau, C., Lassalle, P., Perez, T., De Seze, J., Brunaud-Danel, V., Destée, A., Just, N., Low levels of the vascular endothelial growth factor in CSF from early ALS patients (2004) Neurology, 62, pp. 2127-2129
Canosa, A., Calvo, A., Barberis, M., Brunetti, M., Restagno, G., Cammarosano, S., Ilardi, A., Moglia, C., Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor (2015) Amyotroph. Lateral Scler. Front. Degener., 16, pp. 129-130
Lambrechts, D., Poesen, K., Fernández-Santiago, R., Al-Chalabi, A., Del Bo, R., Van, P.W., Vught, S., Carmeliet, P., Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype (2009) J. Med. Genet., 46, pp. 840-846
Chen, D., Shen, L., Wang, L., Lu, A., Zhang, H., Zhang, X., Zhang, Y., Zhang, J., Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis (2007) Amyotroph. Lateral Scler., 8, pp. 144-149
Chen, W., Saeed, M., Mao, H., Siddique, N., Dellefave, L., Hung, W.Y., Deng, H.X., Siddique, T., Lack of association of VEGF promoter polymorphisms with sporadic ALS (2006) Neurology, 67, pp. 508-510
Del, R., Scarlato, B.M., Ghezzi, S., Martinelli-Boneschi, F., Corti, S., Locatelli, F., Santoro, D., Comi, G.P., Absence of angiogenic genes modification in Italian ALS patients (2008) Neurobiol. Aging, 29, pp. 314-316
Gros-Louis, F., Laurent, S., Lopes, A.A., Khoris, J., Meininger, V., Camu, W., Rouleau, G.A., Absence of mutations in the hypoxia response element of VEGF in ALS (2003) Muscle Nerve, 28, pp. 774-775
Van Vught, P.W., Sutedja, N.A., Veldink, J.H., Koeleman, B.P., Groeneveld, G.J., Wijmenga, C., Uitdehaag, B.M., Van den Berg, L.H., Lack of association between VEGF polymorphisms and ALS in a Dutch population (2005) Neurology, 65, pp. 1643-1645
Zhang, Y., Zhang, H., Fu, Y., Song, H., Wang, L., Zhang, J., Fan, D., VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients (2006) Amyotroph. Lateral Scler., 7, pp. 119-122
Brockington, A., Wokke, B., Nixon, H., Hartley, J., Shaw, P.J., Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis (2007) BMC Med. Genet., 8, p. 23
Cataldi, M., The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases (2013) Curr. Neuropharmacol., 11, pp. 276-297
Kalaria, R.N., Small vessel disease and Alzheimer's dementia: pathological considerations (2002) Cerebrovasc. Dis., 13, pp. S48-S52
Meyer, E.P., Ulmann-Schuler, A., Staufenbiel, M., Krucker, T., Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 3587-3592
Bozzao, A., Floris, R., Baviera, M.E., Apruzzese, A., Simonetti, G., Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load (2001) AJNR Am. J. Neuroradiol., 22, pp. 1030-1036
Matsuda, H., Cerebral blood flow and metabolic abnormalities in Alzheimer's disease (2001) Ann. Nucl. Med., 15, pp. 85-92
Ellis, R.J., Olichney, J.M., Thal, L.J., Mirra, S.S., Morris, J.C., Beekly, D., Heyman, A., Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV (1996) Neurology, 46, pp. 1592-1596
Esiri, M.M., Wilcock, G.K., Cerebral amyloid angiopathy in dementia and old age (1986) J. Neurol. Neurosurg. Psychiatry, 49, pp. 1221-1226
Love, S., Miners, J.S., Cerebral hypoperfusion and the energy deficit in Alzheimer's disease (2016) Brain Pathol., 26, pp. 607-617
Kalaria, R.N., Cohen, D.L., Premkumar, D.R., Nag, S., LaManna, J.C., Lust, W.D., Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia (1998) Brain Res. Mol. Brain Res., 62, pp. 101-105
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., Kumar, P., Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia (2002) Neurobiol. Aging, 23, pp. 237-243
Thirumangalakudi, L., Samany, P.G., Owoso, A., Wiskar, B., Grammas, P., Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease (2006) J. Alzheimers Dis., 10, pp. 111-118
Barker, R., Ashby, E.L., Wellington, D., Barrow, V.M., Palmer, J.C., Kehoe, P.G., Esiri, M.M., Love, S., Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia (2014) Brain, 137, pp. 1524-1532
Provias, J., Jeynes, B., Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease (2014) Curr. Neurovasc. Res., 11, pp. 202-209
Mateo, I., Llorca, J., Infante, J., Rodríguez-Rodríguez, E., Fernández-Viadero, C., Peña, N., Berciano, J., Combarros, O., Low serum VEGF levels are associated with Alzheimer's disease (2007) Acta Neurol. Scand., 116, pp. 56-58
Craig-Schapiro, R., Kuhn, M., Xiong, C., Pickering, E.H., Liu, J., Misko, T.P., Perrin, R.J., DM, H., Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis (2011) PLoS One, 6, p. e18850
Leung, Y.Y., Toledo, J.B., Nefedov, A., Polikar, R., Raghavan, N., Xie, S.X., Farnum, M., Wang, L.S., Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study (2015) Alzheimers Dement. (Amst.)., 1, pp. 339-348
Hohman, T.J., Bell, S.P., Jefferson, A.L., Alzheimer's disease neuroimaging initiative. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease (2015) JAMA Neurol., 72, pp. 520-529
Chapuis, J., Tian, J., Shi, J., Bensemain, F., Cottel, D., Lendon, C., Amouyel, P., Lambert, J.C., Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease (2006) Neurobiol. Aging, 27, pp. 1212-1215
Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli Boneschi, F., Fenoglio, C., Galbiati, S., Virgilio, R., Comi, G.P., Vascular endothelial growth factor gene variability is associated with increased risk for AD (2005) Ann. Neurol., 57, pp. 373-380
Landgren, S., Palmér, M.S., Skoog, I., Minthon, L., Wallin, A., Andreasen, N., Zetterberg, M., Zetterberg, H., No association of VEGF polymorphims with Alzheimer's disease (2010) Neuromol. Med., 12, pp. 224-228
Liu, S.Y., Zeng, F.F., Chen, Z.W., Wang, C.Y., Zhao, B., Li, K.S., Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis (2013) CNS Neurosci. Ther., 19, pp. 469-476
He, D., Lu, W., Chang, K., Liu, Y., Zhang, J., Zeng, Z., Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis (2013) Gene, 518, pp. 296-302
Johnson, N.A., Jahng, G.H., Weiner, M.W., Miller, B.L., Chui, H.C., Jagust, W.J., Gorno-Tempini, M.L., Schuff, N., Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience (2005) Radiology, 234, pp. 851-859
Paris, D., Patel, N., DelleDonne, A., Quadros, A., Smeed, R., Mullan, M. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis (2004) Neurosci. Lett., 366, pp. 80-85
Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., Mullan, M., Inhibition of angiogenesis by Abeta peptides (2004) Angiogenesis, 7, pp. 75-85
Patel, N.S., Mathura, V.S., Bachmeier, C., Beaulieu-Abdelahad, D., Laporte, V., Weeks, O., Mullan, M., Paris, D., Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2 (2010) J. Neurochem., 112, pp. 66-76
Wang, P., Xie, Z.H., Guo, Y.J., Zhao, C.P., Jiang, H., Song, Y., Zhu, Z.Y., Bi, J.Z., VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease (2011) Biochem. Biophys. Res. Commun., 411, pp. 620-626
Garcia, K.O., Ornellas, F.L., Martin, P.K., Patti, C.L., Mello, L.E., Frussa-Filho, R., Han, S.W., Longo, B.M., Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease (2014) Front. Aging Neurosci., 6, p. 30
Religa, P., Cao, R., Religa, D., Xue, Y., Bogdanovic, N., Westaway, D., Marti, H.H., Cao, Y., VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival (2013) Sci. Rep., 3, p. 2053
Pitzer, M.R., Sortwell, C.E., Daley, B.F., McGuire, S.O., Marchionini, D., Fleming, M., Collier, T.J., Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted andcultured embryonic ventral mesencephalic cells (2003) Exp. Neurol., 182, pp. 435-445
Silverman, W.F., Krum, J.M., Mani, N., Rosenstein, J.M., Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures (1999) Neuroscience, 90, pp. 1529-1541
Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Date, I., Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease (2004) Eur. J. Neurosci., 19, pp. 1494-1504
Tian, Y.Y., Tang, C.J., Wang, J.N., Feng, Y., Chen, X.W., Wang, L., Qiao, X., Sun, S.G., Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors (2007) Neurosci. Lett., 421, pp. 239-244
Ding, Y.H., Luan, X.D., Li, J., Rafols, J.A., Guthinkonda, M., Diaz, F.G., Ding, Y., Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke (2004) Curr. Neurovasc. Res., 1, pp. 411-420
Ding, Y.H., Li, J., Zhou, Y., Rafols, J.A., Clark, J.C., Ding, Y., Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise (2006) Curr. Neurovasc. Res., 3, pp. 15-23
Villar-Cheda, B., Sousa-Ribeiro, D., Rodriguez-Pallares, J., Rodriguez-Perez, A.I., Guerra, M.J., Labandeira-Garcia, J.L., Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease (2009) J. Cereb. Blood Flow. Metab., 29, pp. 230-234
Faucheux, B.A., Bonnet, A.M., Agid, Y., Hirsch, E.C., Blood vessels change in the mesencephalon of patients with Parkinson's disease (1999) Lancet, 353, pp. 981-982
Wada, K., Arai, H., Takanashi, M., Fukae, J., Oizumi, H., Yasuda, T., Mizuno, Y., Mochizuki, H., Expression levels of vascular endothelial growth factor and its recept ors in Parkinson's disease (2006) Neuroreport, 17, pp. 705-709
Pienaar, I.S., Lee, C.H., Elson, J.L., McGuinness, L., Gentleman, S.M., Kalaria, R.N., Dexter, D.T., Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease (2015) Neurobiol. Dis., 74, pp. 392-405
Cui, W., Li, W., Han, R., Mak, S., Zhang, H., Hu, S., Rong, J., Han, Y., PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis (2011) Neurochem. Int., 59, pp. 945-953
Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C.H., Hansson, O., Increased CSF biomarkers of angiogenesis in Parkinson disease (2015) Neurology, 85, pp. 1834-1842
Yao, Y., Tsirka, S.E., Monocyte chemoattractant protein-1 and the blood-brain barrier (2014) Cell. Mol. Life Sci., 71, pp. 683-697
Rite, I., Machado, A., Cano, J., Venero, J.L., Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons (2007) J. Neurochem., 101, pp. 1567-1582
Muñoz, A., Garrido-Gil, P., Dominguez-Meijide, A., Labandeira-Garcia, J.L., Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β (2014) Exp. Neurol., 261, pp. 720-732
Newton, S.S., Collier, E.F., Hunsberger, J., Adams, D., Terwilliger, R., Selvanayagam, E., Duman, R.S., Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors (2003) J. Neurosci., 23, pp. 10841-10851
Nicoletti, J.N., Shah, S.K., McCloskey, D.P., Goodman, J.H., Elkady, A., Atassi, H., Hylton, D., Croll, S.D., Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus (2008) Neuroscience, 151, pp. 232-241
Nikitidou, L., Kanter-Schlifke, I., Dhondt, J., Carmeliet, P., Lambrechts, D., Kokaia, M., VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures (2012) PLoS One, 7, p. e40535
McCloskey, D.P., Croll, S.D., Scharfman, H.E., Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures (2005) J. Neurosci., 25, pp. 8889-8897
Cammalleri, M., Martini, D., Ristori, C., Timperio, A.M., Bagnoli, P., Vascular endothelial growth factor up-regulation in the mouse hippocampus and its role in the control of epileptiform activity (2011) Eur. J. Neurosci., 33, pp. 482-498
Vezzani, A., Friedman, A., Dingledine, R.J., The role of inflammation in epileptogenesis (2013) Neuropharmacology, 69, pp. 16-24
Shimada, T., Takemiya, T., Sugiura, H., Yamagata, K., Role of inflammatory mediators in the pathogenesis of epilepsy (2014) Mediat. Inflamm., 2014, p. 901902
Morin-Brureau, M., Lebrun, A., Rousset, M.C., Fagni, L., Bockaert, J., de Bock, F., Lerner-Natoli, M., Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways (2011) J. Neurosci., 31, pp. 10677-10688
Rhim, T., Lee, D.Y., Lee, M., Drug delivery systems for the treatment of ischemic stroke (2013) Pharm. Res., 30, pp. 2429-2444
Eppler, S.M., Combs, D.L., Henry, T.D., Lopez, J.J., Ellis, S.G., Yi, J.H., Annex, B.H., Zioncheck, T.F., A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans (2002) Clin. Pharmacol. Ther., 72, pp. 20-32
Stefanini, M.O., Wu, F.T., Mac Gabhann, F., Popel, A.S., A compartment model of VEGF distribution in blood, healthy and diseased tissues (2008) BMC Syst. Biol., 2, p. 77
Vempati, P., Popel, A.S., Mac Gabhann, F., Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning (2014) Cytokine Growth Factor Rev., 25, pp. 1-19
Keyt, B.A., Berleau, L.T., Nguyen, H.V., Chen, H., Heinsohn, H., Vandlen, R., Ferrara, N., The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency (1996) J. Biol. Chem., 271, pp. 7788-7795
Lauer, G., Sollberg, S., Cole, M., Krieg, T., Eming, S.A., Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site (2002) FEBS Lett., 531, pp. 309-313
Thorne, R.G., Pronk, G.J., Padmanabhan, V., Frey, W.H., 2nd, Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration (2004) Neuroscience, 127, pp. 481-496
Yang, J.P., Liu, H.J., Cheng, S.M., Wang, Z.L., Cheng, X., Yu, H.X., Liu, X.F., Direct transport of VEGF from the nasal cavity to brain (2009) Neurosci. Lett., 449, pp. 108-111
Thorne, R.G., Frey, W.H., II, Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations (2001) Clin. Pharmacokinet., 40, pp. 907-946
Gu, F., Amsden, B., Neufeld, R., Sustained delivery of vascular endothelial growth factor with alginate beads (2004) J. Control. Release, 96, pp. 463-472
Lee, K.W., Yoon, J.J., Lee, J.H., Kim, S.Y., Jung, H.J., Kim, S.J., Joh, J.W., Lee, S.K., Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan (2004) Transplant. Proc., 36, pp. 2464-2465
Semete, B., Booysen, L., Lemmer, Y., Kalombo, L., Katata, L., Verschoor, J., Swai, H.S., In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems (2010) Nanomedicine, 6, pp. 662-671
Golub, J.S., Kim, Y.T., Duvall, C.L., Bellamkonda, R.V., Gupta, D., Lin, A.S., Weiss, D., Guldberg, R.E., Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth (2010) Am. J. Physiol. Heart Circ. Physiol., 298, pp. H1959-H1965
Formiga, F.R., Pelacho, B., Garbayo, E., Abizanda, G., Gavira, J.J., Simon-Yarza, T., Mazo, M., Blanco-Prieto, M.J., Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model (2010) J. Control. Release, 147, pp. 30-37
Herrán, E., Pérez-González, R., Igartua, M., Pedraz, J.L., Carro, E., Hernández, R.M., VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease (2013) J., Control,l Release, 170, pp. 111-119
Herran, E., Perez-Gonzalez, R., Igartua, M., Pedraz, J.L., Carro, E., Hernandez, R.M., Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer's Disease After Implantation of VEGF-loaded PLGA Nanospheres (2015) Curr. Alzheimer Res., 12, pp. 932-940
Herrán, E., Ruiz-Ortega, J.Á., Aristieta, A., Igartua, M., Requejo, C., Lafuente, J.V., Ugedo, L., Hernández, R.M., In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease (2013) Eur. J. Pharm. Biopharm., 85 (3), pp. 1183-1190
Herrán, E., Requejo, C., Ruiz-Ortega, J.A., Aristieta, A., Igartua, M., Bengoetxea, H., Ugedo, L., Hernández, R.M., Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease (2014) Int. J. Nanomed., 9, pp. 2677-2687
Ju, R., Wen, Y., Gou, R., Wang, Y., Xu, Q., The experimental therapy on brain ischemia by improvement of local angiogenesis with tissue engineering in the mouse (2014) Cell Transplant., 23, pp. S83-S95
Zhu, J., Jiang, Y., Xu, G., Liu, X., Intranasal administration: a potential solution for cross-BBB delivering neurotrophic factors (2012) Histol. Histopathol., 27, pp. 537-548
Andrade, C., Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression (2015) J. Clin. Psychiatry, 76, pp. 628-631
Derry, C.J., Derry, S., Moore, R.A., Sumatriptan (intranasal route of administration) for acute migraine attacks in adults (2012) Cochrane Database Syst. Rev., 2
Dietrich, E., Gums, J.G., Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain (2012) Ann. Pharmacother., 46, pp. 1382-1391
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.J., Le Guen, M., Devillier, P., Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids (2012) Pharmacol. Ther., 134, pp. 366-379
Kerr, D., Dietze, P., Kelly, A.M., Intranasal naloxone for the treatment of suspected heroin overdose (2008) Addiction, 103, pp. 379-386
Kronenberg, R.H., Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration (2002) J. Pain Palliat. Care Pharmacother., 16, pp. 27-35
Murphy, A., O'Sullivan, R., Wakai, A., Grant, T.S., Barrett, M.J., Cronin, J., McCoy, S.C., Kandamany, N., Intranasal fentanyl for the management of acute pain in children (2014) Cochrane Database Syst. Rev., 10. , (CD009942)
Pires, A., Fortuna, A., Alves, G., Falcão, A., Intranasal drug delivery: how, why and what for? (2009) J. Pharm. Pharm. Sci., 12, pp. 288-311
Rapoport, A.M., Bigal, M.E., Tepper, S.J., Sheftell, F.D., Intranasal medications for the treatment of migraine and cluster headache (2004) CNS Drugs, 18, pp. 671-685
Robinson, A., Wermeling, D.P., Intranasal naloxone administration for treatment of opioid overdose (2014) Am. J. Health Syst. Pharm., 71, pp. 2129-2135
Santangelo, B., Micieli, F., Marino, F., Reynaud, F., Cassandro, P., Carfora, A., Petrella, R., Vesce, G., Plasma concentrations and sedative effects of a dexmedetomidine, midazolam, and butorphanol combination after transnasal administration in healthy rabbits (2016) J. Vet. Pharm. Ther., 39, pp. 408-411
Sibley, T., Jacobsen, R., Salomone, J., Successful administration of intranasal glucagon in the out-of-hospital environment (2013) Prehosp. Emerg. Care, 17, pp. 98-102
Wolfe, T.R., Bernstone, T., Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases (2004) J. Emerg. Nurs., 30, pp. 141-147
Guardia Clausi, M., Paez, P.M., Pasquini, L.A., Pasquini, J.M., Inhalation of growth factors and apo-transferrin to protect and repair the hypoxic-ischemic brain (2016) Pharmacol. Res., 109, pp. 81-85
Graff, C.L., Pollack, G.M., Nasal drug administration: potential for targeted central nervous system delivery (2005) J. Pharm. Sci., 94, pp. 1187-1195
Tayebati, S.K., Nwankwo, I.E., Amenta, F., Intranasal drug delivery to the central nervous system: present status and future outlook (2013) Curr. Pharm. Des., 19, pp. 510-526
Spetter, M.S., Hallschmid, M., Intranasal neuropeptide administration to target the human brain in health and disease (2015) Mol. Pharm., 12 (8), pp. 2767-2780
Sun, J., Wei, Z.Z., Gu, X., Zhang, J.Y., Zhang, Y., Li, J., Wei, L., Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice (2015) Exp. Neurol., 272, pp. 78-87
Zhao, Q., Hu, J., Xiang, J., Gu, Y., Jin, P., Hua, F., Zhang, Z., Ye, X., Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke (1624) Brain Res., 2015, pp. 489-496
Illum, L., Transpot of drugs from the nasal cavity to the central nervous system (2000) Eur. J. Pharm. Sci., 11, pp. 1-18
Kapoor, M., Cloyd, J.C., Siegel, R.A., A review of intranasal formulations for the treatment of seizure emergencies (2016) J. Control Release, 237, pp. 147-159
Matsune, S., Ohori, J., Yoshifuku, K., Kurono, Y., Effect of vascular endothelial growth factor on nasal vascular permeability (2010) Laryngoscope, 120, pp. 844-848
Henry, T., Annex, B., Azrin, M., Double blind placebo controlled trial of recombinant human vascular endothelial growth factor: the VIVA trial (1999) J. Am. Coll. Cardiol., 33, p. 384A. , (Abstract)
Laham, R.J., Sellke, F.W., Edelman, E.R., Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial (1999) Circulation, 100, pp. 1865-1871
Laitinen, M., Hartikainen, J., Hiltunen, M.O., Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty (2000) Hum. Gene Ther., 11, pp. 263-270
Losordo, D.W., Vale, P.R., Symes, J.F., Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia (1998) Circulation, 98, pp. 2800-2804
Rosengart, T.K., Lee, L.Y., Patel, S.R., Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease (1999) Circulation, 100, pp. 468-474
Schumacher, B., Pecher, P., von Specht, B., Induction of neoangiogenesis in ischemic myocardium by human growth factors (1998) Circulation, 97, pp. 645-650
Springer, M.L., Chen, A.S., Kraft, P.E., Bednarski, M., Blau, H.M., VEGF gene delivery to muscle: potential role for vasculogenesis in adults (1998) Mol. Cell, 2, pp. 549-558
Lee, R.J., Springer, M.L., Blanco-Bose, W.E., Shaw, R., Ursell, P.C., Blau, H.M., VEGF gene delivery to myocardium: deleterious effects of unregulated expression (2000) Circulation, 102, pp. 898-901
Pettersson, A., Nagy, J.A., Brown, L.F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Harvey, V.S., Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor (2000) Lab. Investig., 80, pp. 99-115
Sundberg, C., Nagy, J.A., Brown, L.F., Feng, D., Eckelhoefer, I.A., Manseau, E.J., Dvorak, A.M., Dvorak, H.F., Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery (2001) Am. J. Pathol., 158, pp. 1145-1160
Schwarz, E.R., Speakman, M.T., Patterson, M., Hale, S.S., Isner, J.M., Kedes, L.H., Kloner, R.A., Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat: angiogenesis and angioma formation (2000) J. Am. Coll. Cardiol., 35, pp. 1323-1330
Chen, B., Friedman, B., Cheng, Q., Tsai, P., Schim, E., Kleinfeld, D., Lyden, P.D., Severe blood-brain barrier disruption and surrounding tissue injury (2009) Stroke, 40, pp. e666-e674
Keaney, J., Campbell, M., The dynamic blood-brain barrier (2015) FEBS J., 282, pp. 4067-4079
Montagne, A., Nation, D.A., Pa, J., Sweeney, M.D., Toga, A.W., Zlokovic, B.V., Brain imaging of neurovascular dysfunction in Alzheimer's disease (2016) Acta Neuropathol., 131, pp. 687-707
Popescu, B.O., Toescu, E.C., Popescu, L.M., Bajenaru, O., Muresanu, D.F., Schultzberg, M., Bogdanovic, N., Blood-brain barrier alterations in ageing and dementia (2009) J. Neurol. Sci., 283, pp. 99-106
Prakash, R., Carmichael, S.T., Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury (2015) Curr. Opin. Neurol., 28, pp. 556-564
Stolp, H.B., Dziegielewska, K.M., Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases (2009) Neuropathol. Appl. Neurobiol., 35, pp. 132-146
Ueno, M., Chiba, Y., Matsumoto, K., Murakami, R., Fujihara, R., Kawauchi, M., Miyanaka, H., Nakagawa, T., Blood-brain barrier damage in vascular dementia (2016) Neuropathology, 36, pp. 115-124
Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders (2011) Nat. Rev. Neurosci., 12, pp. 723-738
Zlokovic, B.V., The blood-brain barrier in health and chronic neurodegenerative disorders (2008) Neuron, 57, pp. 178-201
Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., Dvorak, H.F., Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid (1983) Science, 219, pp. 983-985
Horowitz, A., Seerapu, H.R., Regulation of VEGF signaling by membrane traffic (2012) Cell Signal., 24, pp. 1810-1820
Nakayama, M., Berger, P., Coordination of VEGF receptor trafficking and signaling by coreceptors (2013) Exp. Cell Res., 319, pp. 1340-1347
Argaw, A.T., Gurfein, B.T., Zhang, Y., Zameer, A., John, G.R., VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown (2009) Proc. Natl. Acad. Sci. USA, 106, pp. 1977-1982
Fischer, S., Wobben, M., Marti, H.H., Renz, D., Schaper, W., Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1 (2002) Microvasc. Res., 63, pp. 70-80
Ghassemifar, R., Lai, C.M., Rakoczy, P.E., VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells (2006) Cell Tissue Res, 323, pp. 117-125
Wang, W., Dentler, W.L., Borchardt, R.T., VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly (2001) Am. J. Physiol. Heart Circ. Physiol., 280, pp. H434-H440
Argaw, A.T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J.N., Mahase, S., John, G.R., Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease (2012) J. Clin. Investig., 122, pp. 2454-2468
Suzuki, Y., Nagai, N., Yamakawa, K., Muranaka, Y., Hokamura, K., Umemura, K., Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice (2015) J. Cereb. Blood Flow. Metab., 35, pp. 2021-2031
Kanazawa, M., Igarashi, H., Kawamura, K., Takahashi, T., Kakita, A., Takahashi, H., Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment (2011) J. Cereb. Blood Flow. Metab., 31, pp. 1461-1474
Reeson, P., Tennant, K.A., Gerrow, K., Wang, J., Weiser Novak, S., Thompson, K., Lockhart, K.L., Brown, C.E., Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner (2015) J. Neurosci., 35, pp. 5128-5143
Lee, I.L., Li, P.S., Yu, W.L., Shen, H.H., Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited (2011) Protein Expr. Purif., 76, pp. 54-58
Cohen, T., Gitay-Goren, H., Neufeld, G., Levi, B.Z., High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system (1992) Growth Factors, 7, pp. 131-138
Pizarro, S.A., Gunson, J., Field, M.J., Dinges, R., Khoo, S., Dalal, M., Lee, M., Schmelzer, C.H., High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications (2010) Protein Expr. Purif., 72, pp. 184-193
Scheidegger, P., Weiglhofer, W., Suarez, S., Kaser-Hotz, B., Steiner, R., Ballmer-Hofer, K., Jaussi, R., Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs (1999) Biol. Chem., 380, pp. 1449-1454
Mandal, K., Kent, S.B., Total chemical synthesis of biologically active vascular endothelial growth factor (2011) Angew. Chem. Int. Ed. Engl., 50, pp. 8029-8033
Bae, D.G., Kim, T.D., Li, G., Yoon, W.H., Chae, C.B., Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis (2005) Clin. Cancer Res., 11, pp. 2651-2661
Basile, A., Del Gatto, A., Diana, D., Di Stasi, R., Falco, A., Festa, M., Rosati, A., D'Andrea, L.D., Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo (2011) J. Med. Chem., 54, pp. 1391-1400
Foy, K.C., Liu, Z., Phillips, G., Miller, M., Kaumaya, P.T., Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo (2011) J. Biol. Chem., 286, pp. 13626-13637
Rastelli, L., Valentino, M.L., Minderman, M.C., Landin, J., Malyankar, U.M., Lescoe, M.K., Kitson, R., Rabbani, S.A., A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo (2011) Int. J. Oncol., 39, pp. 401-408
Vicari, D., Foy, K.C., Liotta, E.M., Kaumaya, P.T., Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways (2011) J. Biol. Chem., 286, pp. 13612-13625
D'Andrea, L.D., Del Gatto, A., De Rosa, L., Romanelli, A., Pedone, C., Peptides targeting angiogenesis related growth factor receptors (2009) Curr. Pharm. Des., 15, pp. 2414-2429
D'Andrea, L.D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Trimarco, B., Pedone, C., Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 14215-14220
Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., de Vos, A.M., Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor (1997) Cell, 91, pp. 695-704
Diana, D., Ziaco, B., Colombo, G., Scarabelli, G., Romanelli, A., Pedone, C., Fattorusso, R., D'Andrea, L.D., Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide (2008) Chemistry, 14, pp. 4164-4166
Ziaco, B., Diana, D., Capasso, D., Palumbo, R., Celentano, V., Di Stasi, R., Fattorusso, R., D'Andrea, L.D., C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties (2012) Biochem. Biophys. Res. Commun., 424, pp. 290-294
Finetti, F., Basile, A., Capasso, D., Di Gaetano, S., Di Stasi, R., Pascale, M., Turco, C.M., D'Andrea, L.D., Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis (2012) Biochem. Pharmacol., 84, pp. 303-311
Santulli, G., Ciccarelli, M., Palumbo, G., Campanile, A., Galasso, G., Ziaco, B., Altobelli, G.G., Iaccarino, G., In vivo properties of the proangiogenic peptide QK (2009) J. Transl. Med., 7, p. 41
Dudar, G.K., D'Andrea, L.D., Di Stasi, R., Pedone, C., Wallace, J.L., A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner (2008) Am. J. Physiol. Gastrointest. Liver Physiol., 295, pp. G374-G381
Verheyen, A., Peeraer, E., Lambrechts, D., Poesen, K., Carmeliet, P., Shibuya, M., Pintelon, I., Meert, T., Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies (2013) Neuroscience, 244, pp. 77-89
Chan, T.R., Stahl, P.J., Yu, S.M., Matrix-Bound VEGF Mimetic Peptides: design and Endothelial Cell Activation in Collagen Scaffolds (2011) Adv. Funct. Mater., 21, pp. 4252-4262
Kumar, V.A., Taylor, N.L., Shi, S., Wang, B.K., Jalan, A.A., Kang, M.K., Wickremasinghe, N.C., Hartgerink, J.D., Highly angiogenic peptide nanofibers (2015) ACS Nano, 9, pp. 860-868
Lee, J.S., Wagoner Johnson, A.J., Murphy, W.L., A modular, hydroxyapatite-binding version of vascular endothelial growth factor (2010) Adv. Mater., 22, pp. 5494-5498
Leslie-Barbick, J.E., Saik, J.E., Gould, D.J., Dickinson, M.E., West, J.L., The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide (2011) Biomaterials, 32, pp. 5782-5789
Liu, X., Wang, X., Horii, A., Wang, X., Qiao, L., Zhang, S., Cui, F.Z., In vivo studies on angiogenic activity of two designer self-assembling peptide scaffold hydrogels in the chicken embryo chorioallantoic membrane (2012) Nanoscale, 4, pp. 2720-2727
Mulyasasmita, W., Cai, L., Hori, Y., Heilshorn, S.C., Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels (2014) Tissue Eng. Part A., 20, pp. 2102-2114
Stahl, P.J., Chan, T.R., Shen, Y.I., Sun, G., Gerecht, S., Yu, S.M., Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization (2014) Adv. Funct. Mater., 24, pp. 3213-3225
Suárez-González, D., Barnhart, K., Migneco, F., Flanagan, C., Hollister, S.J., Murphy, W.L., Controllable mineral coatings on PCL scaffolds as carriers for growth factor release (2012) Biomaterials, 33, pp. 713-721
Webber, M.J., Tongers, J., Newcomb, C.J., Marquardt, K.T., Bauersachs, J., Losordo, D.W., Stupp, S.I., Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair (2011) Proc. Natl. Acad. Sci. USA, 108, pp. 13438-13443
Pignataro, G., Ziaco, B., Tortiglione, A., Gala, R., Cuomo, O., Vinciguerra, A., Lapi, D., Cataldi, M., Neuroprotective effect of vegf-mimetic peptide qk in experimental brain ischemia induced in rat by middle cerebralartery occlusion (2015) ACS Chem. Neurosci., 6, pp. 1517-1525
Zhang, Y., Furumura, M., Morita, E., Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165 (2008) Growth Factors, 26, pp. 125-131
Diana, D., Basile, A., De Rosa, L., Di Stasi, R., Auriemma, S., Arra, C., Pedone, C., D'Andrea, L.D., β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity (2011) J. Biol. Chem., 286, pp. 41680-41691
Diana, D., De Rosa, L., Palmieri, M., Russomanno, A., Russo, L., La Rosa, C., Milardi, D., Fattorusso, R., Long range Trp-Trp interaction initiates the folding pathway of a pro-angiogenic β-hairpin peptide (2015) Sci. Rep., 5, p. 16651
Di Stasi, R., Diana, D., Capasso, D., Palumbo, R., Romanelli, A., Pedone, C., Fattorusso, R., D'Andrea, L.D., VEGFR1(D2) in drug discovery: expression and molecular characterization (2010) Biopolymers, 94 (6), pp. 800-809
Diana, D., Russomanno, A., De Rosa, L., Di Stasi, R., Capasso, D., Di Gaetano, S., Romanelli, A., Fattorusso, R., Functional binding surface of a β-hairpin VEGF receptor targeting peptide determined by NMR spectroscopy in living cells (2015) Chemistry, 21, pp. 91-95
De Rosa, L., Finetti, F., Diana, D., Di Stasi, R., Auriemma, S., Romanelli, A., Fattorusso, R., D'Andrea, L.D., Miniaturizing VEGF: peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response (2016) Sci. Rep., 6, p. 31295
VEGF mimic peptides: Potential applications in central nervous system therapeutics
VEGF is expressed in central nervous system and its expression increases in hypoxia and in inflammatory brain disorders. A wealth of data suggests that VEGF may exert neuroprotective activities and promote neuroregeneration in disease status. Moreover, the risk of developing certain neurological disorders may be dependent on dysfunction in the VEGF system. Therefore, a strong rationale does exist to suggest that VEGF-based therapeutics could be implemented in conditions such as stroke or amyotrophic lateral sclerosis and experimental data supporting this hypothesis have been obtained. However, the unfavorable pharmacokinetic profile of this growth factor, and concerns on its safety have limited the development of VEGF as a therapeutic tool for neurological disorders. In this review, we discuss why a new class of VEGF-mimic peptides holds promises to become a safer, cheaper and more easily manageable tool for central nervous system therapeutics. Focal Points ● Bench: The analysis of the effects of small peptides reproducing one or more regions of VEGF may help understanding basic issues on the structure-activity relationship of this growth factor.● Bedside: Small VEGF-mimic peptides could have better pharmacokinetic and/or toxicological properties than VEGF and be, therefore, potentially suitable for use in human diseases.● Community: VEGF-mimic peptides-based therapeutics could help reducing the burden of severe neurodegenerative disorders that cannot be efficiently treated with currently available drugs. © 2017 European Society for Translational Medicine
VEGF is expressed in central nervous system and its expression increases in hypoxia and in inflammatory brain disorders. A wealth of data suggests that VEGF may exert neuroprotective activities and promote neuroregeneration in disease status. Moreover, the risk of developing certain neurological disorders may be dependent on dysfunction in the VEGF system. Therefore, a strong rationale does exist to suggest that VEGF-based therapeutics could be implemented in conditions such as stroke or amyotrophic lateral sclerosis and experimental data supporting this hypothesis have been obtained. However, the unfavorable pharmacokinetic profile of this growth factor, and concerns on its safety have limited the development of VEGF as a therapeutic tool for neurological disorders. In this review, we discuss why a new class of VEGF-mimic peptides holds promises to become a safer, cheaper and more easily manageable tool for central nervous system therapeutics. Focal Points ● Bench: The analysis of the effects of small peptides reproducing one or more regions of VEGF may help understanding basic issues on the structure-activity relationship of this growth factor.● Bedside: Small VEGF-mimic peptides could have better pharmacokinetic and/or toxicological properties than VEGF and be, therefore, potentially suitable for use in human diseases.● Community: VEGF-mimic peptides-based therapeutics could help reducing the burden of severe neurodegenerative disorders that cannot be efficiently treated with currently available drugs. © 2017 European Society for Translational Medicine
VEGF mimic peptides: Potential applications in central nervous system therapeutics
VEGF mimic peptides: Potential applications in central nervous system therapeutics
Other filter: ([btitle,keywords] "Alzheimer Disease" O ...
Allocca M, Linguanti F, Calcagni ML, Cistaro A, Gaudieri V, Guerra UP, Morbelli S, Nobili F, Pappata S, Sestini S, Volterrani D, Berti V, For The Neurology Study Group Of The Italian Association Of Nuclear M
* Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study (6 views)
J Clin Med (ISSN: 2077-0383linking), 2021 Oct 25; 10(21): N/D-N/D.
Impact Factor: 4.963
View Export to BibTeX Export to EndNote
Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A, Morbelli S, Nobili F, Pappata S, Volterrani D, Gobbo CL
* Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps (6 views)
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070linking), 2021 Jul; 48(8): 2486-2499.
Impact Factor: 9.236
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (70 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Rendina A, Drongitis D, Donizetti A, Fucci L, Milan G, Tripodi F, Giustezza F, Postiglione A, Pappata S, Ferrari R, Bossù P, Angiolillo A, Di Costanzo A, Caiazzo M, Vitale E
* CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia (94 views)
J Neuropathol Exp Neurol (ISSN: 0022-3069linking), 2020 Jul 10; 79(8): 891-901.
Impact Factor: 3.51
View Export to BibTeX Export to EndNote
Dubbioso R, Ruggiero L, Esposito M, Tarantino P, De Angelis M, Aruta F, Pappata S, Ugga L, Piperno A, Iorio R, Santoro L, Iodice R, Manganelli F
* Different cortical excitability profiles in hereditary brain iron and copper accumulation (131 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2020 Mar; 41(3): 679-685.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F
* Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? (231 views)
Front Mol Neurosci (ISSN: 1662-5099, 1662-5099linking, 1662-5099electronic), 2018 Nov 13; 11: 414-414.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappata S
* Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity (918 views)
Neuroimage (ISSN: 1053-8119linking), 2018 Aug 1; 176: 246-258.
Impact Factor: 5.835
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (706 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (361 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (538 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Zimbone S, Monaco I, Giani F, Pandini G, Copani AG, Giuffrida ML, Rizzarelli E
* Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells (727 views) (PDF 197 views)
Aging Cell (ISSN: 1474-9726, 1474-9718linking), 2017 Nov 01; 17(1): N/D-N/D.
Impact Factor: 7.627
View Export to BibTeX Export to EndNote
Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D
* Inhibition of Abeta Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry (401 views) (PDF 194 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2017 Jun 09; N/D: N/D-N/D.
Impact Factor: 4.211
View Export to BibTeX Export to EndNote
Grasso G, Santoro AM, Lanza V, Sbardella D, Tundo GR, Ciaccio C, Marini S, Coletta M, Milardi D
* The double faced role of copper in Ab homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration (268 views)
Coordination Chemistry Reviews, 2017 Jun; N/D: 1-22.
Impact Factor: 13.324
View Export to BibTeX Export to EndNote
Florenzano F, Veronica C, Ciasca G, Ciotti MT, Pittaluga A, Olivero G, Feligioni M, Iannuzzi F, Latina V, Sciacca MFM, Sinopoli A, Milardi D, Pappalardo G, De Spirito M, Papi M, Atlante A, Bobba A, Borreca A, Calissano P, Amadoro G
* Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies (262 views)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2017 Apr 22; N/D: N/D-N/D.
Impact Factor: 5.168
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A
* Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis? (350 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2017; 60(3): 1097-1106.
Impact Factor: 3.476
View Export to BibTeX Export to EndNote
Gargiulo S, Gramanzini M, Coda ARD, Megna R, Panico M, Mancini M, Pappata S
* Animal Care in a Mouse Model of Amyotrophic Lateral Sclerosis Studied with [18F]DPA-714 Micro-PET/CT (259 views)
Comparative Medicine, 2016 Feb; 66(1): 76-76.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Gargiulo S, Anzilotti S, Coda AR, Gramanzini M, Greco A, Panico M, Vinciguerra A, Zannetti A, Vicidomini C, Dolle F, Pignataro G, Quarantelli M, Annunziato L, Brunetti A, Salvatore M, Pappata S
* Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT (823 views) (PDF 302 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2016 Jan 27; 43(7): 1348-1359.
Impact Factor: 7.277
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Grasso GI, Pietropaolo A, Vecchio G
* Trehalose-8-hydroxyquinoline conjugates as antioxidant modulators of Aβ aggregation (942 views)
Rsc Adv (ISSN: 2046-2069), 2016; 6(53): 47229-47236.
Impact Factor: 3.108
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (526 views)
Front Cell Neurosci (ISSN: 1662-5102), 2015 Aug 7; 9(AUGUST): 297-297.
Impact Factor: 4.609
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (758 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Giacomelli C, Trincavelli ML, Satriano C, Hansson O, La Mendola D, Rizzarelli E, Martini C
* Copper (II) ions modulate Angiogenin activity in human endothelial cells (422 views)
Int J Biochem Cell B (ISSN: 1357-2725), 2015 Mar; 60: 185-196.
Impact Factor: 3.905
View Export to BibTeX Export to EndNote
Cervo A, Cocozza S, Saccà F, Giorgio SM, Morra VB, Tedeschi E, Marsili A, Vacca G, Palma V, Brunetti A, Quarantelli M
* The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis (422 views)
Eur J Radiol (ISSN: 0720-048x), 2015 Jan; 84(1): 151-157.
Impact Factor: 2.593
View Export to BibTeX Export to EndNote
Merlo S, Basile L, Giuffrida ML, Sortino MA, Guccione S, Copani A
* Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity (323 views)
J Nat Prod (ISSN: 0163-3864), 2015; 78(11): 2704-2711.
Impact Factor: 3.662
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (426 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (498 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Salvatore E, Tedeschi E, Mollica C, Vicidomini C, Varrone A, Coda ARD, Brunetti A, Salvatore M, De Michele G, Filla A, Pappata S
* Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study (376 views)
Mov Disord (ISSN: 0885-3185, 1531-8257, 0885-3185linking), 2014 May; 29(6): 780-786.
Impact Factor: 5.68
View Export to BibTeX Export to EndNote
Testi S, Peluso S, Fabrizi GM, Antenora A, Russo CV, Pappata S, Padovani A, Ferrarini M, Filla A
* A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia (289 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 41(3): 709-714.
Impact Factor: 4.151
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Rizzarelli E
* Carnosine and Cognitive Deficits (171 views)
Diet And Nutr In Dement And Cogn Decline (ISSN: 9780-1240793979780124078246), 2014; N/D: 973-982.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (537 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, Haridas H, Esposito G, Cataldo S, Pignataro B, Milardi D, Rizzarelli E
* Carnosine Inhibits Abeta(42) Aggregation By Perturbing The H-Bond Network In And Around The Central Hydrophobic Cluster (697 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2013 Mar 18; 14(5): 583-592.
Impact Factor: 3.06
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A
* Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (1006 views)
Mol Neurobiol (ISSN: 0893-7648), 2012 Dec; 46(3): 605-613.
Impact Factor: 5.471
View Export to BibTeX Export to EndNote
Grasso G, Salomone F, Tundo GR, Pappalardo G, Ciaccio C, Spoto G, Pietropaolo A, Coletta M, Rizzarelli E
* Metal ions affect insulin-degrading enzyme activity (465 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Dec; 117: 351-358.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W
* Alzheimer's disease-associated neurotoxic peptide amyloid-beta impairs base excision repair in human neuroblastoma cells (460 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2012 Nov 13; 13(11): 14766-14787.
Impact Factor: 2.464
View Export to BibTeX Export to EndNote
Pascual B, Prieto E, Arbizu J, Marti-climent JM, Penuelas I, Quincoces G, Zarauza R, Pappata S, Masdeu JC
* Decreased carbon-11-flumazenil binding in early Alzheimer's disease (404 views) (PDF 259 views)
Brain (ISSN: 0006-8950, 1460-2156electronic, 0006-8950linking), 2012 Sep; 135(Pt9): 2817-2825.
Impact Factor: 9.915
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (626 views)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
View Export to BibTeX Export to EndNote
Grasso G, Giuffrida ML, Rizzarelli E
* Metallostasis And Amyloid Beta-Degrading Enzymes (932 views)
Metallomics (ISSN: 1756-5901, 1756-591x, 1756-591xelectronic), 2012 Sep; 4(9): 937-949.
Impact Factor: 4.099
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, La Mendola D, Nicoletti VG, Rizzarelli E
* The inorganic perspectives of neurotrophins and Alzheimer's disease (522 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Jun; 111: 130-137.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Saccà F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G, Carotenuto B, Marsili A, Palma V, De Michele G, Brunetti A, Brescia Morra V, Filla A, Salvatore M
* A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (775 views)
J Neurol (ISSN: 1432-1459, 0340-5354, 1432-1459electronic), 2012 Jan; 259(1): 132-138.
Impact Factor: 3.578
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (958 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Arena G, Fattorusso R, Grasso G, Grasso GI, Isernia C, Malgieri G, Milardi D, Rizzarelli E
* Zinc(II) complexes of ubiquitin: speciation, affinity and binding features (559 views)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2011 Oct 4; 17(41): 11596-11603.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (880 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (424 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Damante CA, Ösz K, Nagy Z, Grasso G, Pappalardo G, Rizzarelli E, Sóvágó I
* Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of A beta(1-16)-polyethylenglycol-ylated peptide: Implications in Alzheimer's disease (455 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2011 Jun 20; 50(12): 5342-5350.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (584 views)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (553 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (748 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, Coletta M, Rizzarelli E
* Copper(I) and Copper(II) Inhibit A beta Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease (576 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2011 Feb 25; 17(9): 2752-2762.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (542 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Vicidomini C, Milan G, De Falco C, Sansone V, Iavarone A, Comerci M, Loré E, Panico M, Quarantelli M, Postiglione A, Salvatore M
* SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment (503 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jun; 37(6): 1156-1163.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G
* Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation (819 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806.
Impact Factor: 8.017
View Export to BibTeX Export to EndNote
De Leva MF, Filla A, Criscuolo C, Tessa A, Pappata S, Quarantelli M, Bilo L, Peluso S, Antenora A, Longo DL, Santorelli FM, De Michele G
* Complex phenotype in an Italian family with a novel mutation in SPG3A (740 views)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2010 Mar; 257(3): 328-331.
Impact Factor: 3.853
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (675 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M, Grasso DM, La Rosa C
* Unveiling the unfolding pathway of FALS associated G37R SOD1 mutant: A computational study (337 views)
Mol Biosyst (ISSN: 1742-206x), 2010; 6(6): 1032-1039.
Impact Factor: 3.825
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (571 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (633 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (835 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (533 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD, Pedone C, Trimarco B, Iaccarino G
* In vivo properties of the proangiogenic peptide QK (415 views)
J Transl Med (ISSN: 1479-5876, 1479-5876electronic, 1479-5876linking), 2009 Jun 8; 7: 41-41.
Impact Factor: 3.407
View Export to BibTeX Export to EndNote
La Mendola D, Pietropaolo A, Pappalardo G, Zannoni C, Rizzarelli E
* Prion Proteins Leading to Neurodegeneration (vol 5, pg 579, 2008) (233 views)
Current Alzheimer Research (ISSN: 1567-2050), 2009 Jun; 6(3): N/D-N/D.
Impact Factor: 4.971
View Export to BibTeX Export to EndNote
Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Double-Blind, Placebo-Controlled, Randomized Trial of Growth Hormone as Add-On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: Preliminary MRS, Hormonal, and Population Analysis (395 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
View Export to BibTeX Export to EndNote
Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Randomized Trial of Growth Hormone as Add. On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis (320 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 76(9): N/D-N/D.
Impact Factor: 8.172
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (358 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1171 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
La Mendola D, Pietropaolo A, Pappalardo G, Zannoni C, Rizzarelli E
* Prion proteins leading to neurodegeneration (420 views)
Current Alzheimer Research (ISSN: 1567-2050), 2008 Dec; 5(6): 579-590.
Impact Factor: 4.132
View Export to BibTeX Export to EndNote
Caraci F, Busceti C, Biagioni F, Aronica E, Mastroiacovo F, Cappuccio I, Battaglia G, Bruno V, Caricasole A, Copani A, Nicoletti
* The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders (384 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2008 Dec; 33(12): 2401-2406.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Pappata S, Salvatore E, Postiglione A
* In vivo imaging of neurotransmission and brain receptors in dementia (482 views) (PDF 259 views)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Impact Factor: 1.811
View Export to BibTeX Export to EndNote
Bellia F, Amorini AM, La Mendola D, Vecchio G, Tavazzi B, Giardina B, Di Pietro V, Lazzarino G, Rizzarelli E
* New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity (444 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2008 Feb; 43(2): 373-380.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (634 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (452 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (720 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Copani A, Caraci F, Hoozemans J, Calafiore M, Sortino M, Nicoletti F
* The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death (481 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2007 Apr; 1772(4): 409-412.
Impact Factor: 3.078
View Export to BibTeX Export to EndNote
Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E
* Abeta(25-35) And Its C- And/Or N-Blocked Derivatives: Copper Driven Structural Features And Neurotoxicity (613 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Feb 15; 85(3): 623-633.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (613 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Bosco P, Caraci F, Copani A, Spada R, Sortino M, Salluzzo R, Salemi M, Nicoletti F, Ferri R
* The CDC2 I-G-T haplotype associated with the APOE ε4 allele increases the risk of sporadic Alzheimer's disease in Sicily (372 views)
Neurosci Lett (ISSN: 0304-3940), 2007; 419(3): 195-198.
Impact Factor: 2.085
View Export to BibTeX Export to EndNote
Esposito L, Pedone C, Vitagliano L
* Molecular dynamics analyses of cross-beta-spine steric zipper models: beta-sheet twisting and aggregation (727 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2006 Sep 1; 103(31): 11533-11538.
Impact Factor: 9.643
View Export to BibTeX Export to EndNote
Copani A, Hoozemans JJM, Caraci F, Calafiore M, Van Haastert ES, Veerhuis R, Rozemuller AJM, Aronica E, Sortino MA, Nicoletti F
* Dna Polymerase-Beta Is Expressed Early In Neurons Of Alzheimer'S Disease Brain And Is Loaded Into Dna Replication Forks In Neurons Challenged With Beta-Amyloid (491 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2006; 26(43): 10949-10957.
Impact Factor: 2.117
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (584 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (796 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicoletti F
* Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (543 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2004 Jun 30; 24(26): 6021-6027.
Impact Factor: 2.384
View Export to BibTeX Export to EndNote
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D
* Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide Aβ1-42 by mirror image phage display (701 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2003; 4(8): 748-753.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (443 views) (PDF 309 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies (612 views) (PDF 271 views)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2000 Mar; 11(3): 260-266.
Impact Factor: 1.302
View Export to BibTeX Export to EndNote
Varrone A, Soricelli A, Postiglione A, Salvatore M
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT (312 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Sep; 24(9): 660-665.
Impact Factor: 0.253
View Export to BibTeX Export to EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (548 views) (PDF 595 views)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic, 0740-3194linking), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli A, Grossi D, Romano M, Mainenti PP, Ruocco A, Fragrassi N, Chiacchio L, Milan G, De Chiara S, Brunetti A
Changes in cerebral blood flow during cognitive activation evaluated by single photon emission computed tomography in patients with Alzheimer's disease (449 views)
Alzheimer S Res (ISSN: 1356-918x), 1997 Jun; 3(3): 93-99.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Soricelli A, Varrone A, Acampa W, Postiglione A, Salvatore M, Lassen N
Brain perfusion with Tc-99m HMPAO and neuronal loss with 123-iomazenil in Alzheimer disease (323 views)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1996 Nov; 201: N/D-N/D.
Impact Factor: 4.989
View Export to BibTeX Export to EndNote
Soricelli A, Postiglione A, GrivetFojaja M, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen N
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (416 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1996 Oct; 23(10): 1323-1328.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
* Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study (6 views)
J Clin Med (ISSN: 2077-0383linking), 2021 Oct 25; 10(21): N/D-N/D.
Impact Factor: 4.963
View Export to BibTeX Export to EndNote
Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A, Morbelli S, Nobili F, Pappata S, Volterrani D, Gobbo CL
* Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps (6 views)
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070linking), 2021 Jul; 48(8): 2486-2499.
Impact Factor: 9.236
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (70 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Rendina A, Drongitis D, Donizetti A, Fucci L, Milan G, Tripodi F, Giustezza F, Postiglione A, Pappata S, Ferrari R, Bossù P, Angiolillo A, Di Costanzo A, Caiazzo M, Vitale E
* CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia (94 views)
J Neuropathol Exp Neurol (ISSN: 0022-3069linking), 2020 Jul 10; 79(8): 891-901.
Impact Factor: 3.51
View Export to BibTeX Export to EndNote
Dubbioso R, Ruggiero L, Esposito M, Tarantino P, De Angelis M, Aruta F, Pappata S, Ugga L, Piperno A, Iorio R, Santoro L, Iodice R, Manganelli F
* Different cortical excitability profiles in hereditary brain iron and copper accumulation (131 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2020 Mar; 41(3): 679-685.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F
* Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? (231 views)
Front Mol Neurosci (ISSN: 1662-5099, 1662-5099linking, 1662-5099electronic), 2018 Nov 13; 11: 414-414.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappata S
* Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity (918 views)
Neuroimage (ISSN: 1053-8119linking), 2018 Aug 1; 176: 246-258.
Impact Factor: 5.835
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (706 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (361 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (538 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Zimbone S, Monaco I, Giani F, Pandini G, Copani AG, Giuffrida ML, Rizzarelli E
* Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells (727 views) (PDF 197 views)
Aging Cell (ISSN: 1474-9726, 1474-9718linking), 2017 Nov 01; 17(1): N/D-N/D.
Impact Factor: 7.627
View Export to BibTeX Export to EndNote
Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D
* Inhibition of Abeta Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry (401 views) (PDF 194 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2017 Jun 09; N/D: N/D-N/D.
Impact Factor: 4.211
View Export to BibTeX Export to EndNote
Grasso G, Santoro AM, Lanza V, Sbardella D, Tundo GR, Ciaccio C, Marini S, Coletta M, Milardi D
* The double faced role of copper in Ab homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration (268 views)
Coordination Chemistry Reviews, 2017 Jun; N/D: 1-22.
Impact Factor: 13.324
View Export to BibTeX Export to EndNote
Florenzano F, Veronica C, Ciasca G, Ciotti MT, Pittaluga A, Olivero G, Feligioni M, Iannuzzi F, Latina V, Sciacca MFM, Sinopoli A, Milardi D, Pappalardo G, De Spirito M, Papi M, Atlante A, Bobba A, Borreca A, Calissano P, Amadoro G
* Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies (262 views)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2017 Apr 22; N/D: N/D-N/D.
Impact Factor: 5.168
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A
* Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis? (350 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2017; 60(3): 1097-1106.
Impact Factor: 3.476
View Export to BibTeX Export to EndNote
Gargiulo S, Gramanzini M, Coda ARD, Megna R, Panico M, Mancini M, Pappata S
* Animal Care in a Mouse Model of Amyotrophic Lateral Sclerosis Studied with [18F]DPA-714 Micro-PET/CT (259 views)
Comparative Medicine, 2016 Feb; 66(1): 76-76.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Gargiulo S, Anzilotti S, Coda AR, Gramanzini M, Greco A, Panico M, Vinciguerra A, Zannetti A, Vicidomini C, Dolle F, Pignataro G, Quarantelli M, Annunziato L, Brunetti A, Salvatore M, Pappata S
* Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT (823 views) (PDF 302 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2016 Jan 27; 43(7): 1348-1359.
Impact Factor: 7.277
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Grasso GI, Pietropaolo A, Vecchio G
* Trehalose-8-hydroxyquinoline conjugates as antioxidant modulators of Aβ aggregation (942 views)
Rsc Adv (ISSN: 2046-2069), 2016; 6(53): 47229-47236.
Impact Factor: 3.108
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (526 views)
Front Cell Neurosci (ISSN: 1662-5102), 2015 Aug 7; 9(AUGUST): 297-297.
Impact Factor: 4.609
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (758 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Giacomelli C, Trincavelli ML, Satriano C, Hansson O, La Mendola D, Rizzarelli E, Martini C
* Copper (II) ions modulate Angiogenin activity in human endothelial cells (422 views)
Int J Biochem Cell B (ISSN: 1357-2725), 2015 Mar; 60: 185-196.
Impact Factor: 3.905
View Export to BibTeX Export to EndNote
Cervo A, Cocozza S, Saccà F, Giorgio SM, Morra VB, Tedeschi E, Marsili A, Vacca G, Palma V, Brunetti A, Quarantelli M
* The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis (422 views)
Eur J Radiol (ISSN: 0720-048x), 2015 Jan; 84(1): 151-157.
Impact Factor: 2.593
View Export to BibTeX Export to EndNote
Merlo S, Basile L, Giuffrida ML, Sortino MA, Guccione S, Copani A
* Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity (323 views)
J Nat Prod (ISSN: 0163-3864), 2015; 78(11): 2704-2711.
Impact Factor: 3.662
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (426 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (498 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Salvatore E, Tedeschi E, Mollica C, Vicidomini C, Varrone A, Coda ARD, Brunetti A, Salvatore M, De Michele G, Filla A, Pappata S
* Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study (376 views)
Mov Disord (ISSN: 0885-3185, 1531-8257, 0885-3185linking), 2014 May; 29(6): 780-786.
Impact Factor: 5.68
View Export to BibTeX Export to EndNote
Testi S, Peluso S, Fabrizi GM, Antenora A, Russo CV, Pappata S, Padovani A, Ferrarini M, Filla A
* A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia (289 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 41(3): 709-714.
Impact Factor: 4.151
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Rizzarelli E
* Carnosine and Cognitive Deficits (171 views)
Diet And Nutr In Dement And Cogn Decline (ISSN: 9780-1240793979780124078246), 2014; N/D: 973-982.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (537 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, Haridas H, Esposito G, Cataldo S, Pignataro B, Milardi D, Rizzarelli E
* Carnosine Inhibits Abeta(42) Aggregation By Perturbing The H-Bond Network In And Around The Central Hydrophobic Cluster (697 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2013 Mar 18; 14(5): 583-592.
Impact Factor: 3.06
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A
* Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (1006 views)
Mol Neurobiol (ISSN: 0893-7648), 2012 Dec; 46(3): 605-613.
Impact Factor: 5.471
View Export to BibTeX Export to EndNote
Grasso G, Salomone F, Tundo GR, Pappalardo G, Ciaccio C, Spoto G, Pietropaolo A, Coletta M, Rizzarelli E
* Metal ions affect insulin-degrading enzyme activity (465 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Dec; 117: 351-358.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W
* Alzheimer's disease-associated neurotoxic peptide amyloid-beta impairs base excision repair in human neuroblastoma cells (460 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2012 Nov 13; 13(11): 14766-14787.
Impact Factor: 2.464
View Export to BibTeX Export to EndNote
Pascual B, Prieto E, Arbizu J, Marti-climent JM, Penuelas I, Quincoces G, Zarauza R, Pappata S, Masdeu JC
* Decreased carbon-11-flumazenil binding in early Alzheimer's disease (404 views) (PDF 259 views)
Brain (ISSN: 0006-8950, 1460-2156electronic, 0006-8950linking), 2012 Sep; 135(Pt9): 2817-2825.
Impact Factor: 9.915
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (626 views)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
View Export to BibTeX Export to EndNote
Grasso G, Giuffrida ML, Rizzarelli E
* Metallostasis And Amyloid Beta-Degrading Enzymes (932 views)
Metallomics (ISSN: 1756-5901, 1756-591x, 1756-591xelectronic), 2012 Sep; 4(9): 937-949.
Impact Factor: 4.099
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, La Mendola D, Nicoletti VG, Rizzarelli E
* The inorganic perspectives of neurotrophins and Alzheimer's disease (522 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Jun; 111: 130-137.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Saccà F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G, Carotenuto B, Marsili A, Palma V, De Michele G, Brunetti A, Brescia Morra V, Filla A, Salvatore M
* A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (775 views)
J Neurol (ISSN: 1432-1459, 0340-5354, 1432-1459electronic), 2012 Jan; 259(1): 132-138.
Impact Factor: 3.578
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (958 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Arena G, Fattorusso R, Grasso G, Grasso GI, Isernia C, Malgieri G, Milardi D, Rizzarelli E
* Zinc(II) complexes of ubiquitin: speciation, affinity and binding features (559 views)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2011 Oct 4; 17(41): 11596-11603.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (880 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (424 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Damante CA, Ösz K, Nagy Z, Grasso G, Pappalardo G, Rizzarelli E, Sóvágó I
* Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of A beta(1-16)-polyethylenglycol-ylated peptide: Implications in Alzheimer's disease (455 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2011 Jun 20; 50(12): 5342-5350.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (584 views)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (553 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (748 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, Coletta M, Rizzarelli E
* Copper(I) and Copper(II) Inhibit A beta Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease (576 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2011 Feb 25; 17(9): 2752-2762.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (542 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Vicidomini C, Milan G, De Falco C, Sansone V, Iavarone A, Comerci M, Loré E, Panico M, Quarantelli M, Postiglione A, Salvatore M
* SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment (503 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jun; 37(6): 1156-1163.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G
* Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation (819 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806.
Impact Factor: 8.017
View Export to BibTeX Export to EndNote
De Leva MF, Filla A, Criscuolo C, Tessa A, Pappata S, Quarantelli M, Bilo L, Peluso S, Antenora A, Longo DL, Santorelli FM, De Michele G
* Complex phenotype in an Italian family with a novel mutation in SPG3A (740 views)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2010 Mar; 257(3): 328-331.
Impact Factor: 3.853
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (675 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M, Grasso DM, La Rosa C
* Unveiling the unfolding pathway of FALS associated G37R SOD1 mutant: A computational study (337 views)
Mol Biosyst (ISSN: 1742-206x), 2010; 6(6): 1032-1039.
Impact Factor: 3.825
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (571 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (633 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (835 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (533 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD, Pedone C, Trimarco B, Iaccarino G
* In vivo properties of the proangiogenic peptide QK (415 views)
J Transl Med (ISSN: 1479-5876, 1479-5876electronic, 1479-5876linking), 2009 Jun 8; 7: 41-41.
Impact Factor: 3.407
View Export to BibTeX Export to EndNote
La Mendola D, Pietropaolo A, Pappalardo G, Zannoni C, Rizzarelli E
* Prion Proteins Leading to Neurodegeneration (vol 5, pg 579, 2008) (233 views)
Current Alzheimer Research (ISSN: 1567-2050), 2009 Jun; 6(3): N/D-N/D.
Impact Factor: 4.971
View Export to BibTeX Export to EndNote
Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Double-Blind, Placebo-Controlled, Randomized Trial of Growth Hormone as Add-On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: Preliminary MRS, Hormonal, and Population Analysis (395 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
View Export to BibTeX Export to EndNote
Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Randomized Trial of Growth Hormone as Add. On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis (320 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 76(9): N/D-N/D.
Impact Factor: 8.172
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (358 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1171 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
La Mendola D, Pietropaolo A, Pappalardo G, Zannoni C, Rizzarelli E
* Prion proteins leading to neurodegeneration (420 views)
Current Alzheimer Research (ISSN: 1567-2050), 2008 Dec; 5(6): 579-590.
Impact Factor: 4.132
View Export to BibTeX Export to EndNote
Caraci F, Busceti C, Biagioni F, Aronica E, Mastroiacovo F, Cappuccio I, Battaglia G, Bruno V, Caricasole A, Copani A, Nicoletti
* The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders (384 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2008 Dec; 33(12): 2401-2406.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Pappata S, Salvatore E, Postiglione A
* In vivo imaging of neurotransmission and brain receptors in dementia (482 views) (PDF 259 views)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Impact Factor: 1.811
View Export to BibTeX Export to EndNote
Bellia F, Amorini AM, La Mendola D, Vecchio G, Tavazzi B, Giardina B, Di Pietro V, Lazzarino G, Rizzarelli E
* New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity (444 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2008 Feb; 43(2): 373-380.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (634 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (452 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (720 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Copani A, Caraci F, Hoozemans J, Calafiore M, Sortino M, Nicoletti F
* The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death (481 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2007 Apr; 1772(4): 409-412.
Impact Factor: 3.078
View Export to BibTeX Export to EndNote
Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E
* Abeta(25-35) And Its C- And/Or N-Blocked Derivatives: Copper Driven Structural Features And Neurotoxicity (613 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Feb 15; 85(3): 623-633.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (613 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Bosco P, Caraci F, Copani A, Spada R, Sortino M, Salluzzo R, Salemi M, Nicoletti F, Ferri R
* The CDC2 I-G-T haplotype associated with the APOE ε4 allele increases the risk of sporadic Alzheimer's disease in Sicily (372 views)
Neurosci Lett (ISSN: 0304-3940), 2007; 419(3): 195-198.
Impact Factor: 2.085
View Export to BibTeX Export to EndNote
Esposito L, Pedone C, Vitagliano L
* Molecular dynamics analyses of cross-beta-spine steric zipper models: beta-sheet twisting and aggregation (727 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2006 Sep 1; 103(31): 11533-11538.
Impact Factor: 9.643
View Export to BibTeX Export to EndNote
Copani A, Hoozemans JJM, Caraci F, Calafiore M, Van Haastert ES, Veerhuis R, Rozemuller AJM, Aronica E, Sortino MA, Nicoletti F
* Dna Polymerase-Beta Is Expressed Early In Neurons Of Alzheimer'S Disease Brain And Is Loaded Into Dna Replication Forks In Neurons Challenged With Beta-Amyloid (491 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2006; 26(43): 10949-10957.
Impact Factor: 2.117
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (584 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (796 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicoletti F
* Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (543 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2004 Jun 30; 24(26): 6021-6027.
Impact Factor: 2.384
View Export to BibTeX Export to EndNote
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D
* Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide Aβ1-42 by mirror image phage display (701 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2003; 4(8): 748-753.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (443 views) (PDF 309 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies (612 views) (PDF 271 views)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2000 Mar; 11(3): 260-266.
Impact Factor: 1.302
View Export to BibTeX Export to EndNote
Varrone A, Soricelli A, Postiglione A, Salvatore M
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT (312 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Sep; 24(9): 660-665.
Impact Factor: 0.253
View Export to BibTeX Export to EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (548 views) (PDF 595 views)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic, 0740-3194linking), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli A, Grossi D, Romano M, Mainenti PP, Ruocco A, Fragrassi N, Chiacchio L, Milan G, De Chiara S, Brunetti A
Changes in cerebral blood flow during cognitive activation evaluated by single photon emission computed tomography in patients with Alzheimer's disease (449 views)
Alzheimer S Res (ISSN: 1356-918x), 1997 Jun; 3(3): 93-99.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Soricelli A, Varrone A, Acampa W, Postiglione A, Salvatore M, Lassen N
Brain perfusion with Tc-99m HMPAO and neuronal loss with 123-iomazenil in Alzheimer disease (323 views)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1996 Nov; 201: N/D-N/D.
Impact Factor: 4.989
View Export to BibTeX Export to EndNote
Soricelli A, Postiglione A, GrivetFojaja M, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen N
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (416 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1996 Oct; 23(10): 1323-1328.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
89 Records (82 excluding Abstracts).
Total impact factor: 396.301 (361.554 excluding Abstracts).
Total 5 year impact factor: 392.316 (358.725 excluding Abstracts).
Total impact factor: 396.301 (361.554 excluding Abstracts).
Total 5 year impact factor: 392.316 (358.725 excluding Abstracts).
624 views. Last view on Tuesday 21 March 2023, 22:35:57
ibb.cnr.it
